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ABSTRACT 
PROTEIN PHOSPHORYLATION AND DEPHOSPHORYLATION 
IN THE PARIETAL CELL: 
THE ROLE OF THE REGULATORY SUBUNIT 
OF TYPE II CYCLIC AMP-DEPENDENT PROTEIN KINASE 
IN HISTAMINE-STIMULATED ACID SECRETION 
Valerie Anne Asher 
1990 
The role of cAMP in mediating histamine-stimulated parietal cell secretion 
is well established. Traditional views have suggested that the actions of cAMP are 
mediated through the activation of cAMP-dependent protein kinase (CAPK). The 
data presented here suggest a new model for cAMP-mediated acid secretion in 
which dephosphorylation of the regulatory subunit of Type II CAPK (Rll) plays a 
critical role. 
Isolated rabbit parietal cells (85 ± 5% pure) were incubated with either 100 
AiM cimetidine (unstimulated) or a combination of 100 /xM histamine and 10 juM 
forskolin (maximally stimulated) for 45 min. The cells were then homogenized and 
subcellular fractions were prepared to localize phosphorylation changes to specific 
intracellular compartments. Differential centrifugation at 40xg, 4000xg, 14,500xg, 
and 48,500xg was used to prepare the subcellular fractions which were then 
characterized and assayed for endogenous kinase activity using [gamma-32P]-ATP 
as a phosphate donor. Phosphorylated proteins were then resolved using SDS- 
PAGE and autoradiography. 
A 52 kDa protein (pp52) was found to be phosphorylated in the stimulated 
apical membrane fraction and the unstimulated cytosolic fraction. This activity was 

extremely rapid; pp52 was 100% phosphorylated within 45 sec. The kinase was 
dependent on Mg2+ and ATP (Ky, 3 ^M) but could also use GTP as a phosphate 
donor (K,/? 10 /uM). The addition of 10 cAMP to protein samples from stimulated 
apical membrane fractions abolished the phosphorylation of pp52. This inhibitory 
effect of cAMP was found to be due to the presence of a membrane-associated 
phosphatase activity that completely dephosphorylated pp52 within 120 sec. 
Although this phosphatase activity was not inhibited by Zn2+, Mn2+, pyrophos¬ 
phate, or NaF, it was inhibited by the phosphatase inhibitor okadaic acid, at a 
concentration that suggested it was mediated by a Type 1 phosphatase. 
Isoelectric focusing, phosphoamino acid analysis, cAMP-binding studies, and 
immunoprecipitation identified the 52 kDa proteins in both membrane and cytosol 
as the regulatory subunit of Type II CAPK. Immunoprecipitation also suggested 
that the proteins found in membrane and cytosol were two different subtypes of 
Rll. 
Whole cell secretion studies also supported the hypothesis that a 
phosphatase plays a critical role in histamine-stimulated acid secretion. Histamine- 
stimulated [14C]aminopyrine ([14C]AP) uptake was measured in isolated rabbit 
parietal cells in the presence and absence of okadaic acid. Okadaic acid inhibited 
histamine-stimulated [14C]AP uptake with an ID^ of approximately 10 juM. In 
contrast, H-8, an inhibitor of CAPK did not affect histamine-stimulated [,4C]AP 
uptake, suggesting the CAPK may not play a major role in histamine-stimulated 
acid secretion. These results suggest that the histamine-stimulated increase in 
cAMP may stimulate processes other than activation of cAMP-dependent protein 
kinase. 
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INTRODUCTION 
While the formation of gastric and duodenal ulcers is probably determined 
by the balance between destructive and protective factors, it has often been 
observed that ulcers are seen only in the presence of acid. Thus the control of 
acid secretion is of considerable interest in the treatment of ulcer disease. 
However the mechanism of acid secretion is still poorly understood; thus drug 
therapies have been directed primarily at the first and last steps in acid secretion. 
The first step in acid secretion involves hormone-receptor interactions at the 
cell surface. Known stimuli of acid secretion include histamine, acetylcholine, and 
gastrin. The Type II histamine (H2) antagonists competitively bind to histamine 
receptors on the cell surface, thus preventing the endogenous secretagogue from 
initiating acid secretion. Because the various pathways that lead to acid secretion 
are interdependent, these drugs also decrease the amount of acid secreted in 
response to gastrin and cholinergic agents1. Anticholinergic drugs such as 
atropine work in a similar fashion to decrease gastric acid secretion. However, 
because of their serious side effects, more specific antimuscarinics such as the Ml 
antagonist pirenzapine are preferable2, though less efficacious. The final step in 
acid secretion is the actual secretion of protons. Omeprazole, a substituted 
benzimidazole, specifically inhibits the H"/K'-ATPase that is ultimately responsible 
for pumping protons into the lumen of the stomach2. 
While the H2 receptor blockers have made the treatment of peptic ulcer 
disease far more effective, some forms of gastric and duodenal ulceration, such 
as the stress ulcers sometimes seen in patients with shock, burns, sepsis, or 
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trauma, may not be amenable to conventional medical therapies3. This may reflect 
the fact that agents other than acid, such as pepsin, may be involved. However, 
a better understanding of the cellular physiology of acid secretion might enable us 
to treat such patients more effectively. In order to do this the molecular 
mechanism of acid secretion must be defined and the subcellular regulatory 
pathways delineated. This project represents an attempt to illuminate this area by 
examining the role of protein phosphorylation in the secretion of acid by the 
parietal cell. 
The secretagogues that stimulate acid secretion also stimulate a number of 
so-called "second messengers," suggesting that several convergent pathways 
control acid secretion. These second messengers, such as cyclic adenosine 
3' :5'-monophosphate (cAMP) and calcium, are thought to regulate intracellular 
processes by activating protein kinases and phosphatases. These enzymes alter 
the activities of essential protein substrates by adding or removing phosphate 
groups. It is therefore reasonable to postulate that the phosphorylation state of a 
key substrate may play a role in the control of acid secretion. 
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CHAPTER ONE 
ACID SECRETION IN PERSPECTIVE 
THE STOMACH 
While the work presented here has focused on gastric acid secretion, the 
stomach serves many functions. Muscular walls allow it to expand and act as a 
reservoir for food, while peristaltic contractions serve to mix chyme with gastric 
secretions and to empty the gastric contents into the duodenum. The stomach is 
also an endocrine organ, for the antral mucosa contains G-cells that produce 
gastrins, a group of hormones that stimulates acid and pepsinogen secretion, 
gastric and intestinal motility, increased pressure in the lower esophageal 
sphincter, and bicarbonate secretion by the pancreas and liver. The exocrine 
secretions of the stomach include HCI, pepsinogen, intrinsic factor, and mucus. 
The secretion of gastric acid lowers the pH of the gastric contents. This 
acidification serves several purposes. Gastric HCI may sterilize the contents of the 
stomach. It also promotes the conversion of pepsinogen to pepsin and provides 
the low pH necessary for pepsin to catalyze the breakdown of proteins. 
ACID SECRETION: HISTORY 
Given the complexity of gastric function, it is not surprising that the study of 
gastric acid secretion has been enmeshed in controversy. In the past, scientists 
disagreed about whether the stomach secreted acid and if so, which acid it 
produced. Only recently has the parietal cell been identified as the site of acid 
production. Thus it now remains to identify the intracellular processes that mediate 
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gastric HCI secretion. 
The history of the study of acid secretion has been extensively reviewed in 
an excellent review article by Modlin and is briefly summarized here4. Early Greek 
theories of digestion recognized neither the role of the stomach nor the function 
of acid in digestion. Not until the sixteenth century did Paracelsus assert that the 
stomach contains acid and that it is necessary for digestion. He believed that by 
drinking acidic spa waters one introduced acid into the stomach. Jean Baptiste von 
Helmont and Sylvius also held to this chemical theory of digestion but did little to 
further understanding of the nature or source of gastric acid. Indeed von Helmont 
believed the spleen to be the source, while Sylvius maintained that the digestive 
processes of the stomach were mediated by saliva. These contradictory chemical 
theories were coi;ectively challenged by a second school of thought that main¬ 
tained that the stomach’s main function was mechanical. 
In the eighteenth century, experimental science blossomed, and inves¬ 
tigators such as Reaumur, Reuss, Gosse, Stevens, Spallanzani, Scopoli and 
Carminati studied digestion and the contents of the stomach in both humans and 
animals. Scopoli and Spallanzani produced evidence to suggest that the stomach 
contained hydrochloric acid. This was confirmed definitively by William Prout in 
1823, when he presented his paper "On the Nature of Acid and Saline Matters 
Usually Existing in the Stomach of Animals" to the Royal Society of London. In this 
work he showed evidence that hydrochloric acid is found in the gastric juice of 
many different species. He was also able to quantify his data, showing the total 
amount of hydrochloric acid present and relating it to dyspeptic symptoms. This 
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work predated that of William Beaumont, who published his first experiments in 
1826. Nonetheless, complete acceptance of Prout’s theory did not come until this 
century. Various investigators attempted to show that acetic, butyric, lactic, and 
phosphoric acids were secreted by the stomach. Not until 1930 did Dodds and 
Robertson confirm that hydrochloric acid was the sole acid produced by the 
stomach. 
Beginning with Pavlov’s studies on vagal control of gastric secretion, 
scientists began to investigate neural control of acid secretion. At the same time 
other researchers began to elucidate the humoral regulation of the gastrointestinal 
tract, identifying both histamine and gastrin as important regulators of gastric acid 
production. However the exact source of gastric acid remained unknown. 
At the beginning of the nineteenth century Matthias Schleiden and Thomas 
Schwann opened the world of cell biology with the theory that all life is composed 
of cells. Over the next century, the different gastric cell types, including the parietal 
cell, were identified. The parietal cell took its name from the Latin word for wall, 
based on its tendency to bulge outward from the wall of the gastric gland5. It is 
now also known as the oxyntic cell, a name given because of its ability to produce 
acid5. The morphology of the parietal cell was described, with its numerous, large 
mitochondria, cytoplasmic tubulovesicles, and extensive invaginations of the apical 
membrane known as "intracellular" canaliculi despite their apparent continuity with 
the gland lumen8. 
In 1858, Claude Bernard used chemical and microscopic methods in an 
attempt to determine the site of acid formation. Using a precursor of Prussian 
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blue, a colored pH indicator, he injected rabbits, then removed their stomachs for 
microscopic examination. He found the blue color indicative of low pH only in the 
superficial layer of the mucosa; it stained neither the gastric glands nor the canali- 
culi of the parietal cell. Mistakenly, he took this as evidence that the stomach 
secreted a neutral substance that underwent further reaction to become acidic 
within the lumen of the stomach7. 
Later investigators found circumstantial evidence to suggest that the parietal 
cell was indeed the source of gastric HCI. Acid is found only in stomachs that 
contain parietal cells, and the amount produced is proportional to the number of 
parietal cells present58. The presence of acid in the fetal stomach was also found 
to be temporally related to parietal cell differentiation9. The unique morphology of 
the parietal cell seemed well suited for this purpose, with its abundant, large 
mitochondria to provide energy and its extensive, dynamic system of canaliculi. 
These were believed to be a secretory apparatus that cycled between the resting 
and the stimulated states. A number of investigators looked for further evidence 
that the parietal cell was the source of gastric acid. Bradford and Davies used 26 
pH indicator dyes to study isolated amphibian and mammalian gastric mucosa. 
They found that in histamine-stimulated tissue, the contents of the intracellular 
canaliculi had a pH of less than 4.85,10. Kominick used silver to precipitate chlo¬ 
ride and found precipitates in the glandular lumen and vesicles of parietal cells. 
This physical proximity was taken as further evidence that parietal cells are the 
source of gastric HCI5. Later studies looked at isolated rabbit gastric glands with 
interference, electron, and fluorescence microscopy. Parietal cells in histamine- 
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stimulated gastric glands formed intracellular spaces consistent with the expanded 
canalicular network previously described in stimulated cells. The use of the pH- 
dependent fluorescent indicator acridine orange confirmed that the spaces were 
indeed acidic11,12. Another line of investigation developed when HCI secretion was 
found to be dependent on a mechanism requiring ATP and K+: the HT/K'-ATPase. 
A monoclonal antibody developed against the catalytic subunit of this enzyme 
recognized only one kind of cell in the gastric mucosa, the parietal cell13. This 
provided substantial support for the theory that the parietal cell is the source of 
gastric acid. 
PARIETAL CELL MORPHOLOGY 
The simple columnar epithelium that lines the mammalian stomach is 
interrupted by gastric pits, invaginations of the mucosa that lead to one or more 
tubular gastric glands. The gastric glands of the fundus and corpus, known as 
oxyntic glands, contain several types of cells: the oxyntic or parietal cell, the chief 
cell, the mucus neck cell, as well as endocrine cells (Figure 1). The parietal cell 
is the most numerous cell of the corpus, making up about 32% of the corpus 
mucosa5. The normal human stomach contains approximately one billion parietal 
cells9. They are usually found in the neck and isthmus regions of the oxyntic gland 
but can also be found along the base. 
The parietal cell is an oval to pyramidal cell that may be as large as 25 /xM. 
Several features make it morphologically distinctive5. First, it contains abundant, 
large mitochondria to provide the energy necessary for the proton pump. Second, 
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FIGURE 1: The gastric aland. 
Simplified drawing of a tubular gastric gland from the corpus of a mammalian 
stomach showing the basic cell types: mucous neck cells, parietal cells, chief cells, 
and parietal cells. Parietal cells are concentrated in the neck and isthmus of the 
gland, although they are also found along the base. (Adapted from ref. 5). 
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in the resting state, the cytoplasm is filled with smooth, membranous tubulovesi- 
cular structures (Figure 2). Lastly, the cell is penetrated by canalicuii that are 
continuous with the apical membrane of the cell and communicate with the oxyntic 
gland lumen. In the unstimulated cell, the canalicuii are quite small and possess 
short, stubby microvilli as does the apical membrane of the cell. When the parietal 
cell is stimulated with secretagogues that promote acid secretion, the canalicular 
system expands and the microvilli grow longer and more numerous, increasing the 
apical surface area by a factor of four or more. At the same time the tubulovesi- 
cular membranes disappear from the cytoplasm (Figure 2). When secretion stops, 
the microvilli of the canalicular system return to their original state, while the tubulo- 
vesicles reappear in the cytoplasm14,5. Morphometric studies have shown that the 
increase in the apical surface area corresponds to a decrease in that of the 
tubulovesicles15. 
Two hypotheses have attempted to explain these morphological 
changes16,17,18. The osmotic flow or expansion hypothesis contends that the tubulo- 
vesicular membranes are continuous with the apical membrane but that in the 
resting cell the tubulovesicles are supercollapsed. They expand in response to net 
ionic and volume flow, thus creating the apparent structural changes in the cell. 
However experiments that induced the accumulation of water and salt within 
tubulovesicles did not lead to enlargement of the apical membrane17. It therefore 
seemed that osmotic change alone was not sufficient to bring about the 
morphological changes associated with secretion. No further data has been pro¬ 
duced in support of the osmotic flow theory. 
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FIGURE 2: Electron micrographs of resting and histamine-stimulated parietal 
cells. 
Electron micrographs (10,000 x magnification) were prepared from isolated rabbit 
parietal cells prepared as described in Chapter 3. Histamine-stimulated cells were 
incubated with 10 mM histamine for 45 min. In the resting parietal cell (A), 
numerous tubulovesicles fill the cytoplasm. Large numbers of mitochondria are 
also present. In the stimulated parietal cell (B), the tubulovesicles have disappeared 
from the cytoplasm and the canalicular network has become more elaborate. 
(Electron micrographs courtesy of Dr. James Goldenring, Yale University, New 
Haven, CT). 
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Far more credible is the membrane recycling or fusion hypothesis, which 
proposes that the tubulovesicles fuse with the apical membrane upon stimulation 
of the cell. When the cell returns to the resting state these membranes are some¬ 
how retrieved to form tubulovesicles19. Several pieces of evidence support this 
theory. Antibodies directed against the H+/K+-ATPase localized the enzyme to the 
tubulovesicles of the resting cell, with less of the enzyme being found in the apical 
membrane. In contrast, in the stimulated cell, the H+/K+-ATPase was predominately 
found in the apical membrane13, suggesting that the movement of the IT/HC- 
ATPase depends upon the fusion of tubulovesicles with the apical membrane. 
Freeze-fracture electron microscopy has also shown that upon histamine 
stimulation, the particle distribution of the apical membrane changes, becoming 
more like that of the tubulovesicles19. This suggests that the tubulovesicular 
membrane has become part of the apical surface. Other studies of fixed cells with 
macromolecular tracers or extracellular surface stains have failed to show any 
direct communication between the cell surface and the tubulovesicles. However 
when macromolecular tracers were incubated with living cells, prior to fixation, they 
showed up within the tubulovesicles16. This is consistent with the fusion hypothesis 
in that there is no direct communication between the cell surface and tubulo¬ 
vesicles, but that a pathway does exist for the movement of materials between the 
apical membrane and the tubulovesicles. 
Changes in the cytoskeletal architecture of the parietal cell parallel the 
changes in membrane structure. Actin-like filaments are found in the microvilli, 
while other studies have shown microfilaments and microtubules beneath the 
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microvilli20,14 Double labelling of cells with antibodies against actin and spectrin 
showed striking evidence of carbachol-stimulated cytoskeletal reorganization cor¬ 
responding to changes in the membrane structure of stimulated cells21. Disruption 
of actin filaments and microtubules also disrupts parietal cell function. When cyto- 
chalasin, a drug which prevents the elongation of actin filaments, is added to piglet 
mucosa, acid secretion is inhibited22. Similarly, when guinea pig parietal cells were 
treated with colchicine and vinblastine, histamine-stimulated acid production was 
impaired23. These data suggest that cytoskeletal elements may mediate both the 
fusion of tubulovesicles with the apical membrane in the stimulated cell and their 
retrieval when the cell returns to the resting state. 
PARIETAL CELL PHYSIOLOGY 
Methods of study 
in vivo a number of stimuli cause gastric acid secretion: the sight, taste, 
smell and thought of food, gastric distention, proteins and amino acids in the 
stomach, chyme in the duodenum, vagal stimulation, acetylcholine, histamine, and 
gastrin24. Because of the complexity of this system, neither in vivo studies nor 
those using intact gastric mucosa shed much light on the direct effectors of 
parietal cell acid secretion. For this purpose, cell separation techniques, using 
enzymatic digestion and centrifugation, have been developed to facilitate the study 
of viable gastric glands25 and isolated gastric cells. Because of the large size of 
the parietal cell, techniques such as counterflow elutriation and centrifugation on 
density gradients can be used to prepare cells that are up to 90% pure26. More 
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recently a procedure has been developed that allows the culture of highly enriched 
parietal cells, making long-term studies feasible for the first time27. 
Studies of dispersed gastric glands and cells have one important disad¬ 
vantage. With the loss of mucosal polarity, it is no longer possible to measure 
proton secretion directly, since the basolateral membrane secretes a neutralizing 
bicarbonate ion26. Therefore indirect methods have been developed to permit the 
study of parietal cell function in vitro11,26,28. 
The energy requirements of the parietal cell provide one way to assess 
secretory activity. The HT/K -ATPase, the proton pump, requires ATP. This ATP 
is provided by the abundant mitochondria that occupy 30 to 40% of the parietal 
cell cytoplasm. In order to produce ATP, the mitochondria consume oxygen. 
Thus oxygen consumption provides an indirect measure of secretory activity. A 
similar protocol measures the formation of 14C02 from [14C] glucose to determine 
metabolic activity26. 
Another measure of secretory activity makes use of the profound 
morphologic transformation of the stimulated parietal cell. This change can be 
observed in living ceils using either differential interference-contrast microscopy 
(Nomarski optics) or fluorescent microscopy. The latter can be used with acridine 
orange, a weak base that accumulates in acidic spaces and emits a red 
fluorescence at low pH11,26. 
The tendency of weak bases to accumulate in membrane-bound acidic 
spaces is also used in another method. A radioactive weak base such as 
[14C]aminopyrine ([14C]AP), which has a pKa of 6, will accumulate in the acidic 
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spaces of actively secreting parietal cells. Acid sequestration can be quantified 
by simply measuring the radioactivity that remains associated with washed parie¬ 
tal cells after incubation with [14C]AP2628. This method is probably the most widely 
used in the study of parietal cell secretory activity. 
While these methods have helped to overcome one problem encountered 
in the study of acid secretion, others exist that are not so easily solved. 
Particularly troubling are the variations in parietal cell function found among dif¬ 
ferent species. For example, in some mammalian species, including rabbit and 
man, the parietal cell secretes intrinsic factor (IF) as well as HCI29, whereas in other 
species the chief cell is responsible for secreting IF. In nonmammalian vertebrates, 
a single cell type, the oxyntopeptic cell secretes both pepsinogen and acid5. It has 
therefore been difficult to establish whether there exists a generalized mechanism 
of acid secretion with some minor variations between species. However most 
reports support a common mechanism of receptor-mediated proton secretion 
effected by the H7K+-ATPase proton pump. 
The regulation of acid secretion in vivo 
in vivo studies show that paracrine, neurocrine. and endocrine pathways 
influence gastric acid secretion. When the isolated gastric gland or parietal cell is 
studied in vitro, these pathways appear to correspond to three recognized secre- 
tagogues: histamine, acetylcholine, and gastrin (Figure 3). Histamine is found in 
the mast cells of the gastric mucosa, although it is possible that a second cell 
type in the gastric mucosa also produces histamine. The parasympathetic nerve 
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FIGURE 3: Regulatory pathways of the parietal cell. 
Histamine, acetylcholine, and gastrin appear to stimulate the parietal cell; however 
gastrin receptors have been demonstrated only on canine parietal cells. In other 
species gastrin may act indirectly by stimulating the release of histamine. It is not 
yet clear which cell type in the gastric mucosa is the source of histamine. N - 
neuron; X - histamine-producing cell; GC - G cell; Ach - acetylcholine; H - 
histamine; G - gastrin. 
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terminals release acetylcholine. Gastrin, a peptide hormone, is released by the 
gastric endocrine G cells. 
Histamine stimulation of acid secretion 
There is a large body of evidence to support the assertion that histamine 
stimulates gastric acid secretion. Berglindh et ak25'28 first showed that histamine 
stimulated oxygen consumption and [14C]aminopyrine uptake in a dose-dependent 
fashion in isolated rabbit glands with an ED50 of 3 x 106M, reaching a maximum 
after about 30 minutes. Histamine stimulation of parietal cells has also been 
demonstrated in cells from many other species, including pig30, dog31, rat32, guinea 
pig33, frog26, and human34. However there are differences between species in the 
magnitude of the response to secretagogue35. For example histamine-stimulated 
[14C]aminopyrine uptake is greater in rabbit parietal cells than in those of the dog26. 
The response to histamine appears to be mediated through a typical H2 receptor. 
The H2 receptor antagonist cimetidine was found to be a competitive inhibitor of 
histamine-stimulated rabbit gastric gland secretion36. While the H, receptor an¬ 
tagonist mepyramine successfully inhibited histamine-stimulated [14C]aminopyrine 
accumulation in canine cells, it did so at a concentration 105 times higher than that 
required for H, receptor blockade31. Thus histamine and its antagonists appear to 
act through an H2 receptor. 
Histamine stimulation of parietal cells also increases the concentration of 
cyclic adenosine monophosphate (cAMP) in many species, including rabbit36 and 
dog37. This was enhanced in the presence of the phosphodiesterase inhibitor 3- 
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isobutyl-1 -methyl xanthine (IBMX)38. Several facts indicate the involvement of cAMP 
in parietal cell acid secretion. First, the increase in cAMP correlated with histamine 
stimulation of parietal cell function as measured by oxygen consumption and 
[14C]aminopyrine accumulation38. Second, the action of histamine can be en¬ 
hanced by the use of IBMX, which prevents the degradation of cAMP by cAMP 
phosphodiesterase26. Third, the use of forskolin, a specific activator of adenylate 
cyclase, the enzyme that converts ATP to cAMP, increases both parietal cell 
activity and intracellular cAMP39. Lastly, the use of the cell-permeant cAMP 
analogues dibutyryl cAMP (DBcAMP) and 8-bromo-cAMP directly stimulate 
[14C]aminopyrine accumulation in isolated canine parietal cells31. 
While the study of histamine-stimulated parietal cell activity has focused on 
the role of cAMP, a second system may also play a part. Studies using the 
calcium-sensitive dyes quin2 and fura-2 have shown that histamine causes an 
increase in the intracellular calcium ([Ca],)40 41 . Histamine stimulation led to a 
calcium spike within 5 seconds followed by a plateau level that persisted until the 
removal of agonist or the addition of antagonist. The H2 receptor antagonist 
cimetidine specifically blocked this reaction. This increase does not appear to be 
mediated by cAMP, since addition of DBcAMP and IBMX did not affect the intracel¬ 
lular calcium concentration42 43. However forskolin was found to increase cytosolic 
free Ca2+ in rabbit gastric glands40 and pig parietal cells30. The calcium spike oc¬ 
curred in the presence of calcium channel blockers. Thus it seems to represent 
the release of calcium from an intracellular store. In contrast, the plateau that 
appears after the spike appears to depend on the influx of extracellular calcium 
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across the plasma membrane43. The role of the Ca2+ signal in histamine-stimulated 
acid secretion is unclear since chelation of neither extracellular 43 44 nor intracel¬ 
lular44 Ca2+ affected histamine-stimulated uptake of [14C]aminopyrine in rabbit parie¬ 
tal cells. 
Cholinergic stimulation of acid secretion 
Cholinergic agonists such as carbachol have also been shown to affect 
parietal cell secretory activity45 23. When carbachol was added to isolated rabbit 
glands, oxygen consumption, a marker for acid secretion, increased, reaching a 
maximum at 15 to 20 minutes and slowly declining from that point28. This is in 
marked contrast to the pattern seen with histamine stimulation, where peak parietal 
cell activity is sustained at a maximal plateau. The secretory response to 
carbachol in rabbit glands is also weaker than that seen with histamine28. Some 
differences exist between species. In canine parietal cells, carbachol stimulates 
a sustained response that is greater than that of either histamine or gastrin3'. The 
specificity of the response to cholinergic agonists has been shown by the fact that 
it is competitively inhibited by atropine but unaffected by the H2 receptor blocker 
cimetidine31. 
Carbachol appears to act independently of cAMP. The stimulatory effect is 
seen without a corresponding increase in intracellular cAMP38. However, like 
histamine, carbachol stimulates an increase in the intracellular calcium con¬ 
centration of the parietal cell. This increase can be blocked by the muscarinic 
antagonist atropine43. The addition of carbachol leads to the efflux of calcium from 
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intracellular stores, causing a calcium ipike followed by a plateau phase that 
seems to depend on the influx of extracellular calcium43. Because of calcium’s 
known role as a second messenger46, it is tempting to speculate that it plays a role 
in acid secretion. However it has been difficult to prove this connection. It has not 
been possible to use Ca2+ ionophores to study parietal cell proton secretion, 
because they also interfere with H+ concentrations and thereby impair function of 
the proton pump47. However there is some data to suggest that calcium does play 
a part in acid secretion. In medium with a low concentration of Ca2’ (10 5M) amino- 
pyrine accumulation by acetylcholine-stimulated rabbit gastric glands is decreased 
by 70%42. Even more convincing is the fact that use of an intracellular calcium 
chelator (1,2-Bis(2aminophenoxy)ethane-N,N,N’,N’-tetraacetic acid acetoxy methyl 
ester) eliminated both the carbachol-stimulated calcium signal and carbachol- 
stimulated [14C]aminopyrine accumulation in rabbit parietal cells44. 
Gastrin stimulation of acid secretion 
The role of gastrin in stimulating parietal cell acid secretion is somewhat less 
clear than that of histamine or cholinergic agonists. Gastrin receptors have been 
demonstrated only on canine parietal cells using 125l-gastrin as a probe48. In 
addition, parietal cells from different species respond very differently to gastrin. 
When first studied in isolated rabbit gastric glands, gastrin failed to induce in¬ 
creased respiratory activity, increased [14C]aminopyrine accumulation, or 
quantifiable changes in morphology28. Subsequent studies of isolated canine 
parietal cells showed a small increase in parietal cell activity with gastrin stimula- 
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tion. Neither atropine nor cimetidine blocked this response, suggesting that it was 
mediated through a third receptor that was neither cholinergic nor histaminergic31. 
Proglumide, an inhibitor of cholecystokinin, inhibits the effect of gastrin on parietal 
cells but does not appear to affect responses mediated by other receptor types48. 
This probably reflects the fact that cholecystokinin, a peptide hormone, shares a 
common tetrapeptide sequence with gastrin at the carboxyl terminal. Gastrin- 
stimulation of [14C]aminopyrine accumulation was seen when rabbit gastric glands 
were treated with the phosphodiesterase inhibitor IBMX or the sulfhydryl reducing 
agent dithiothreitol (DTT). This response was inhibited by cimetidine49. jQ-Mercap- 
toethanol, which enhances the histamine sensitivity of the rabbit parietal cell, also 
enhanced the gastrin response26. Since gastrin is known to release histamine from 
gastric glands, it is possible that its effects on the rabbit parietal cell are mediated 
by histamine and not by the direct effect on the parietal cell that has been noted 
in the dog26. 
While there are several different regulatory pathways modulating parietal cell 
stimulatory activity, they are clearly interdependent. Histamine, carbachol, and 
gastrin potentiate one another’s actions, producing effects that are greater than the 
sum of their effects alone50,51. Forskolin, which increases the concentration of 
cAMP by activating adenylate cyclase, also potentiates the effect of carbachol40, 
as does the cell-permeant cAMP analogue DBcAMP52. This suggests that the 
potentiating effects of secretagogues are mediated within the cell and not at the 
level of the receptor. 
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Inhibitors of acid secretion 
In considering parietal cell physiology, it is also important to note inhibitors 
of parietal cell function. The competitive muscarinic and H2 antagonists have 
already been mentioned, as has omeprazole, the H+/K+-ATPase inhibitor, which 
is a noncompetitive inhibitor of all parietal cell secretagogues. The prostaglandins 
PGE2 and PGI2 inhibit histamine-stimulated parietal cell function53 as well as the 
histamine-stimulated increase in cAMP37,54 55 56. Somatostatin also acts noncompeti- 
tively to inhibit histamine- and gastrin-stimulated acid secretion in rabbit, rat, and 
guinea pig parietal cells56 57 58. Specific somatostatin receptors have also been 
identified on canine parietal cells59. Somatostatin also inhibits the histamine- 
stimulated increase in cAMP. It is possible that somatostatin acts by inhibiting 
adenylate cyclase60. Pancreastatin, a peptide hormone that shares some sequence 
homology with gastrin, inhibits both histamine- and carbachol-stimulated aminopy- 
rine uptake in rabbit parietal cells61. While pancreastatin inhibited the histamine- 
stimulated increase in cAMP, it had no effect on the carbachol induced calcium 
spike61. The available data suggest that pancreastatin acts to inhibit parietal cell 
signal transduction at several different points61. The inhibitory effects of epidermal 
growth factor (EGF) have also been described and are equally complex. EGF 
inhibits both histamine- and carbachol-stimulated aminopyrine uptake in isolated 
rabbit parietal cells62,63,64. Like pancreastatin, it seems to exert its effect at multiple 
points in the signal transduction pathway63. 
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PROTEIN KINASES AND PROTEIN PHOSPHORYLATION IN THE PARIETAL 
CELL 
Stimuli of gastric parietal cell HCI secretion are also known to increase 
intracellular concentrations of cAMP and Ca2+. In many systems these "second 
messengers" activate cellular enzymes known as protein kinases. Protein kinases 
are able to phosphorylate other proteins. The addition of a phosphate group to 
many proteins alters their biological activities. This mechanism is thought to play 
a role in regulating a wide variety of cellular processes85. Many investigators have 
therefore tried to delineate the role of protein kinases and protein phosphorylation 
in parietal cell acid secretion (Tables I and II.) 
Protein kinases 
Studies focusing on the role of cAMP in the parietal cell have concentrated 
on the cAMP-dependent protein kinase (CAPK). This kinase is a tetramer made 
of two identical regulatory subunits (R) and two identical catalytic subunits (C) 
(Figure 4). In the inactive form, the regulatory subunit is bound to the catalytic 
subunit. When cAMP is bound to the regulatory subunit, the tetramer disas¬ 
sociates and the two catalytic subunits are released as the active enzyme. There 
are two types of CAPK, known as Type I and Type II. These differ only in the 
regulatory subunit; the catalytic subunit is the same for both Type I and Type II 
CAPK. 
Using isolated rabbit gastric glands Jackson et aL66 identified two cytosolic 
cAMP binding proteins with molecular weights of 48 kDa and 58 kDa. These were 
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SOURCE STIMULUS INTRACELLULAR 
LOCATION 
KINASE 
Rabbit FGM 
- 
cytosol cAMP dependent 
(unaffected by K+) 
membrane cAMP dependent 
(decreased by K+) 
Rabbit GG cytosol Zn2+/Mn2+ 
dependent 
Rabbit PC - cytosol, membrane cAMP dependent 
Rabbit PC cytosol Calmodulin 
dependent 
Rabbit PC ? Ca2+/phospholipid 
dependent (PKC) 
Rabbit PC - ? 2 Casein Kinases 
Rabbit PC histamine cytosol cAMP dependent 
(type 1) 
Guinea Pig FGM histamine cytosol cAMP dependent 
Rabbit PC forskolin cytosol, membranes cAMP dependent 
(type II) 
Rabbit PC carbachol ? Ca2+ dependent 
PKC 
Rat FGM membrane Ca^+/Calmodulin 
dependent 
TABLE I: Protein kinases found in gastric tissue and parietal cells. 
For references, see text. Abbreviations: FGM - fundic gastric mucosa; GG - 
gastric glands; PC - parietal cells; PKC - protein kinase C. 
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SOURCE SECRETAGOGUE KINASE 
DEPENDENCE 
INTRACELLULAR 
LOCATION 
SUBSTRATE 
PROTEINS 
Rabbit PC 
histamine 
cytosol 148, 130, 47, 
43 kDa 
membrane 130, 51, 47 
kDa 
none CAMP 
cytosol many, 
esp.131, 
97,84, 47, 
42, 33 kDa 
membrane many, esp 
130, 42, 20, 
22 kDa 
Rabbit PC histamine CAMP cytosol 30 kDa 
Rabbit PC histamine CAMP membrane 27, 40 kDa 
Rabbit GG histamine + 
forskolin 
membrane 80, 120 kDa 
Rabbit PC carbachol 
Ca2+/PKC membrane, 
cytosol 
28, 36 kDa 
PKC ? 2x 66 kDa 
Rabbit PC none calmodulin cytosol 100 kDa 
Rabbit GG none Zn2+/Mn2+ cytosol 33 kDa 
TABLE II: Protein kinase substrates found in gastric tissue and parietal cells. 
For references, see text. Abbreviations: FGM - fundic gastric mucosa; GG 
gastric glands; PC - parietal cells; PKC - protein kinase C. 
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FIGURE 4: Structure of the cAMP-dependent protein kinase. 
The kinase is a tetramer (RjCJ composed of two identical regulatory subunits (R) 
and two identical catalytic subunits (C). Each regulatory subunit has two cAMP 
binding sites. 
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found to correspond to two cytosolic cAMP dependent protein kinases thought to 
be Type I and Type II CAPK. When the glands were stimulated with histamine, 
binding of the azido-cAMP ligand decreased 32 to 44%. This is consistent with the 
hypothesis that when histamine increases endogenous cAMP, it binds to the 
regulatory subunit of CAPK, leaving fewer binding sites available for the exogenous 
ligand. Theoretically this should lead to increased CAPK activity in stimulated cells, 
and in fact several investigators have demonstrated this67,68,69,70,71. Histamine 
stimulation increased the activity of CAPK in both rabbit and guinea pig fundic mu- 
cosa67,68,89. The activation of CAPK was also found to reflect the tissue con¬ 
centration of cAMP70. A more detailed study of CAPK activity in isolated parietal 
cells reported that the Type I isozyme was found predominately in the cytosolic 
fraction while the Type II isozyme was found in both particulate and cytosolic frac¬ 
tions71. Histamine stimulation of these cells was shown to activate only the cytoso¬ 
lic Type I kinase71. In contrast, forskolin was found to stimulate both forms of 
CAPK71. These data suggest that Type I and Type II CAPK are compartmentalized 
within the parietal cell and that histamine stimulation increases local concentra¬ 
tions of cAMP, thus selectively activating the Type I isozyme. 
Other studies have attempted to identify putative substrates of CAPK in the 
parietal cell727374,75. After preincubation with 32P-labe!ed orthophosphate, secreta- 
gogue is added to the tissue preparation. Phosphorylation changes are evalua¬ 
ted by homogenizing the cells, using differential centrifugation to separate soluble 
and particulate material, and using one- and two-dimensional SDS-PAGE followed 
by autoradiography. A number of phosphoproteins have been identified in this 
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way, but it remains to see which of these actually play a role in acid secretion. 
Using this methodology, Chew and Brown’2 have shown that stimulation with 
histamine increases the phosphorylation of 27 and 40 kDa proteins in low speed 
particulate fractions of parietal cells. Forskolin and cAMP analogues also increase 
the phosphorylation of these proteins, suggesting that a cAMP-dependent 
mechanism mediates the phosphorylation increase72. Oddsdottir et aL73 have 
reported that histamine, forskolin, and 8-bromo-cAMP stimulated the phosphory¬ 
lation of a 30 kDa cytosolic protein in rabbit parietal cells. Protein phosphorylation 
began to increase within one minute of the addition of secretagogue and reached 
a maximum at 15 minutes73. Malinowska et aL have found histamine-dependent 
increases in protein phosphorylation in both soluble and particulate fractions74. 
Phosphoproteins of 148, 130, 47, and 43 kDa were detected in the cytosolic frac¬ 
tion, while phosphoproteins of 130, 51, and 47 kDa appeared in the particulate 
fraction. 
Urushidani et aL have done extensive work characterizing a membrane- 
bound phosphoprotein in gastric glands. They examined subcellular fractions of 
histamine-stimulated rabbit gastric glands and found 80 and 120 kDa proteins in 
the heavy particulate fraction75. This same fraction is also greatly enriched in 
H+/K+-ATPase activity, as measured by K+-p-nitrophenyl phosphatase activity, in 
histamine-stimulated gastric glands76. Since FT/K+-ATPase activity can be used 
as a marker for the apical membrane in stimulated cells, this has been referred to 
as the apical-membrane rich fraction. The 80 kDa protein was also phosphory- 
lated when glands were treated with DBcAMP, whereas neither carbachol- 
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stimulation nor chelation of intracellular calcium affected its phosphorylation state77. 
Like the H 7K+-ATPase, the 80 kDa protein is tightly membrane-associated77. The 
80 kDa protein could also be phosphorylated in vitro by the addition of 32P-ATP to 
the apical-membrane rich fraction. The addition of cAMP-dependent protein kinase 
inhibitor blocked this reaction, suggesting that CAPK is at least partly responsible 
for phosphorylating the 80 kDa protein77. Monoclonal antibodies against this 80 
kDa protein have been used to show that within the gastric mucosa, it is found 
only in parietal cells73. Immunocytochemistry further revealed that the 80 kDa pro¬ 
tein is localized to a fine, filamentous network within the parietal cell. This staining 
pattern is similar to that of F-actin. When the cells are stimulated with histamine, 
the distribution of the 80 kDa protein changes to a coarser, rugose pattern iden¬ 
tical to that seen for immunolocalization of the H+/K+-ATPase78. The change in the 
staining pattern of the 80 kDa protein probably reflects the elaboration of the apical 
membrane that is seen in the stimulated cell. 
Far fewer substrates for protein phosphorylation have been identified in 
carbachol-stimulated parietal cells. Carbachol-stimulation increased phosphoryla¬ 
tion of two 66 kDa proteins with different isoelectric points and a 36 kDa protein44. 
Carbachol also induced a transient increase in the phosphorylation of a 28 kDa 
protein44' The 36 and 28 kDa proteins are found in the 100,000 x g supernatant 
and pellet, rather than the apical membrane fractions44. Several pieces of evidence 
support the hypothesis that the carbachol-stimulated calcium signal mediates the 
phosphorylation of these proteins. The calcium ionophore, ionomycin, was able 
to stimulate phosphorylation of the 28 kDa protein, while 12-O-tetradecanoylphor- 
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bol-13-acetate (TPA) was able to stimulate phosphorylation of the two 66 and the 
36 kDa proteins. TPA is a direct activator of the phospholipid-Ca2+-dependent 
protein kinase also known as protein kinase C (PKC). In addition, chelation of 
intracellular calcium blocked phosphorylation of the 36 and 28 kDa proteins, as 
well as the calcium signal and parietal cell secretory activity as measured by 
aminopyrine uptake44. 
in vitro phosphorylation of gastric mucosal membranes prepared from 
homogenized rat fundic mucosa also suggests that Ca+ plays a role in gastric 
protein phosphorylation79. Phosphorylation of an 88 kDa membrane protein was 
dependent on Ca2+ but was not affected by cAMP, cyclic GMP (cGMP), or CAPK 
inhibitor. This activity may represent a Ca2+-calmodulin-dependent kinase, since 
trifluoperazine, an inactivator of calmodulin, blocked this Ca2+-dependent phospho¬ 
rylation. 
Several other protein kinase activities have been described in gastric 
mucosa. In rabbit gastric glands, a Zn2"-dependent kinase activity phosphorylates 
a 33 kDa protein80. However, because this kinase activity was observed in 
homogenates made from a mixed population of cells, it may actually not be 
specific to the parietal cell. In homogenates made from parietal cells, several 
protein kinase activities have been observed, including a Ca2+-phospholipid- 
dependent kinase, two casein kinases that may correspond to casein kinase I and 
II71, and a calmodulin-dependent kinase thought to be calmodulin kinase III81. 
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CHAPTER TWO 
THE TYPE II CAMP-DEPENDENT PROTEIN KINASE 
As discussed in the previous section, earlier work on the parietal cell has 
indicated that protein kinases may play a role in secretagogue-stimulated acid 
secretion. More specifically, the cAMP-dependent protein kinase (CAPK) is 
thought to mediate histamine-stimulated acid secretion. The research presented 
here focuses on the role of the regulatory subunit of the Type II CAPK (Rll). In 
order to place this work in context, the literature on the Type II CAPK and Rll is 
reviewed in this section. 
PROTEIN KINASES-BACKGROUND AND HISTORY 
Protein kinases catalyze the transfer of phosphate groups to substrate 
proteins. Protein phosphorylation has been implicated in the regulation of many 
cell processes, including synaptic transmission82, protein synthesis33, growth84, 
secretion85, smooth muscle contraction and relaxation86, DNA synthesis87, and 
glycogen metabolism88. Although almost a hundred different protein kinases have 
been described, they are all thought to be related, with highly conserved catalytic 
domains89. They can be divided into two broad categories: those that phosphory- 
late serine or threonine residues and those that phosphorylate tyrosine residues89. 
Many of these enzymes are activated when an extracellular effector molecule binds 
to a membrane receptor. This results in a change in the concentration of an intra¬ 
cellular second messenger that in turn activates the kinase. The kinase then 
phosphorylates one or more substrates. As some of these substrates may 
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themselves be protein kinases, the stimulus may lead to a cascade of phosphory¬ 
lation reactions that ultimately produce the physiological response characteristic 
of the effector molecule. 
Protein phosphorylation is an effective and sensitive regulator of cell function 
because of its reversibility. The phosphate groups added by the kinases can be 
removed by either phosphoprotein phosphatases or the reverse reactions of the 
protein kinases themselves30. The mechanism is also made more responsive by 
the fact that substrates are often phosphorylated by multiple kinases, and the 
kinases themselves can act on more than one substrate. • 
The fundamental model for protein kinase activity was provided by work 
done on the regulation of glycogen metabolism88. The enzyme phosphorylase, 
which catalyzes the initial step in glycogen breakdown, was found to exist in two 
forms: an active, phosphorylated form and an inactive, dephosphorylated form. 
Interconversion of the two forms was regulated by two enzymes: phosphorylase 
kinase and phosphorylase phosphatase. Like phosphorylase, phosphorylase 
kinase was also found to exist in two forms, requiring the addition of a phosphate 
group for activation. This implied that a second kinase existed. cAMP was also 
known to play a role in epinephrine- and glucagon-stimulated glycogen break¬ 
down. The relationship of these facts was made clear when Walsh et al. isolated 
the cAMP-dependent protein kinase (CAPK)91. 
This work provided an elegant model for hormone-stimulated regulation 
of a cellular process mediated by the activation and deactivation of protein kinases. 
However it was also significant in that it first identified cyclic AMP-dependent kinase 
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(Figure 5). This enzyme was soon found to be ubiquitous, phosphorylating a wide 
variety of substrates in many organisms and tissues9293 in response to many 
different stimuli. Nor was it confined to a single compartment of the cell. While 
predominately identified in soluble fractions, it was also present in association with 
particulate cellular matter, particularly in brain tissue94,95. 
CYCLIC AMP-DEPENDENT PROTEIN KINASE (CAPK) 
CAPK phosphorylates serine and threonine residues. The enzyme appears 
to recognize these amino acids when a pair of basic amino acids is found in close 
proximity on the amino terminal side96. Phys;. ogical substrates of CAPK include 
other enzymes involved in carbohydrate metabolism as well as troponin I, 
cholesterol esterase, tyrosine hydroxylase, and ATP-citrate lyase97. In addition the 
enzyme exhibits broad substrate specificity in vitro that may not be physiological, 
phosphorylating proteins such as histone, protamine, S-6 ribosomal protein, myelin 
basic protein, and casein97. It has been hypothesized98 but not proven96 that all the 
effects of cAMP are mediated by CAPK. At least one study appears to contradict 
this hypothesis. In rat parotid, inhibition of the cAMP-dependent protein kinase in¬ 
hibited cAMP-dependent protein phosphorylation but did not interfere with cAMP- 
evoked amylase release99. 
In the absence of cAMP, CAPK is inactive. The enzyme is a tetramer, 
composed of two identical regulatory subunits (R) and two identical catalytic 
subunits (C) that bind to each other with high affinity97. Each R subunit has two 
cAMP binding sites. The two sites have differing affinities for cAMP100. However 
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FIGURE 5: The cAMP-dependent protein kinase: mechanism of action. 
Stimulatory and inhibitory external signals interact with receptors on the cell 
surface. These interact in turn with the stimulatory and inhibitory GTP-binding 
proteins, Gt and G,. G, stimulates the enzyme adenylate cyclase (AC) to convert 
ATP to cAMP, whereas G, inhibits this reaction. AC can also be directly stimulated 
by forskolin. The increase in intracellular cAMP activates the cAMP-dependent 
protein kinase by binding to the regulatory subunit (R) and releasing free catalytic 
subunit (C). C catalyzes the addition of a phosphate group (P) to a substrate 
protein (X). The activated protein (X-P) causes a cellular response. 
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cAMP binding to the R subunit is cooperative94. When cAMP binds to the R 
subunit, its affinity for the C subunit is diminished by a factor of 104, and it releases 
the free catalytic subunit97. The formula for this reaction is: 
R2C2 + 4 cAMPr=i R2(cAMP)4 + 2C 97 
The free catalytic subunit is then active in the presence of ATP and Mg2+. This 
activity can be inhibited by adding either a heat-stable inhibitor protein that has 
been purified from rabbit skeletal muscle101 or a synthetic substrate analogue, 
known as CAPK pseudosubstrate102. 
Although the literature commonly refers to CAPK as though it were a single 
enzyme, there are in fact two isozymes103, referred to as Type I and Type II CAPK. 
These were first noted to elute differently from DEAE-cellulose103. The two 
isozymes were found to have different affinities for ATP, cAMP, and the catalytic 
subunit104. While the concentration of CAPK present in a mammalian tissues is 
generally constant105, the relative proportions of the two isozymes vary from tissue 
to tissue93 and between species in the same tissue 06. Subsequently it was dis¬ 
covered that the isozymes differed in the regulatory subunit; the catalytic subunit 
in each was found to be the same. 
Rl and Rll differ in both their chemical and biological properties. While 
review of the literature reveals a range of sizes for each subunit, Rl is generally 
smaller than Rll. Rl has been reported to have a molecular weight between 47 
and 49 kDa, while Rll ranges from 51 to 62 kDa. They have different patterns of 
immunoreactivity; antiserum raised against the Type II kinase does not react with 
the Type I isozyme107. Similarly, peptide mapping of Rl and Rll gave further 
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evidence to support the suggestion that the two forms had different amino acid 
sequences108. Amino acid analysis confirmed this suspicion’09. Final proof was 
provided when the two proteins were sequenced in 1984110,111. Rll also differs from 
Rl in its ability to undergo "autophosphorylation" by the catalytic subunit112. This 
reaction will be more fully discussed in the next section. 
The occurrence in nature of two kinds of regulatory subunit, often found 
within the same cell, suggests that they serve different purposes. Numerous 
studies done in many different systems support this hypothesis. Differential 
activation of the two protein kinase isozymes has been seen in rabbit corpora lutea 
stimulated with human chorionic gonadotropin113, mouse pituitary tumor cells 
stimulated with corticotropin releasing factor114, rat liver stimulated with glucagon115, 
and histamine-stimulated rabbit parietal cells71. In one study, different patterns of 
kinase activation were seen in the same cell line when two different hormones were 
used to stimulate cells116. In cells grown from rat calvaria, parathyroid hormone 
stimulated Types I and II equally, whereas PGE2 stimulated Type II CAPK almost 
exclusively. Site-specific cAMP analogues have also been used to determine 
whether cAMP binding to one of the two cAMP binding sites preferentially activates 
one form of the enzyme. In a human colon cancer line, the site-specific cAMP 
analogue 8-chloro-cAMP decreased the amount of Rl and increased the amount 
of two species of Rll117. Lastly, changes in the relative amounts of Rl and Rll have 
been seen in Friend erythroleukemic cells undergoing differentiation118. 
This differential activation may reflect subcellular compartmentalization of the 
isozymes. Data from several systems, including the rabbit parietal cell, support this 
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hypothesis. In rabbit parietal cells the Type II kinase is found in both soluble and 
particulate fractions, whereas the Type I is found only in soluble fractions71. Simi¬ 
larly, in the rat parotid Rll is the dominant form in the particulate fraction, while Rl 
is concentrated in the soluble fraction119. 
The distribution of CAPK activity has also been studied in forskolin- 
stimulated cells 71,114. Forskolin activates adenylate cyclase, which catalyzes the 
formation of cAMP. When forskolin was used, both forms of CAPK were activated 
equally. These data suggest that specific hormone-receptor interactions may 
activate only a portion of the adenylate cyclase in the cell, increasing the local con¬ 
centration of cAMP, and thus activating only that form of CAPK that is found in 
close proximity. However an alternative possibility is that hormones may initiate 
different modifications to the two proteins, enabling them to respond differently to 
an increase in second messengers. 
Other important differences exist between the two kinds of regulatory 
subunit. However the data presented in this paper focus primarily on the role of 
Rll in histamine-stimulated acid secretion in the isolated rabbit parietal cell. The 
properties of the Type II regulatory subunit are therefore reviewed more completely 
in the next section. 
THE TYPE II REGULATORY SUBUNIT OF CAMP-DEPENDENT PROTEIN 
KINASE 
The regulatory subunit of the Type II CAPK (Rll) can be divided into several 
distinct domains. It is, like Rl, a cAMP-binding protein with two cAMP binding 
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sites100. It also has at least five potential phosphorylation sites per molecule’20. 
However, when isolated from bovine cardiac muscle, Rll in fact contains between 
1.2 and 2.7 mol phosphate/mol Rll monomer121. Rll also possesses a domain that 
acts to inhibit the kinase activity of the catalytic subunit and a region that interacts 
with another Rll monomer to form a dimer97 (Figure 6). 
Autophosphorvlation of Rll 
The tendency of Rll to undergo "autophosphorylation" by the catalytic 
subunit of CAPK is one of its most distinctive features112'122. In the presence of Mg2+ 
and ATP, Rll is phosphorylated at a single serine residue, incorporating 1 mole of 
phosphate per mole of Rll subunit. This reaction demonstrates a broad pH 
optimum (pH 6 to 8.5) and a Kh for ATP of 0.4 juM123. In contrast, the K% for 
exogenous proteins is about 12 ^M123. Because of this high affinity, it has been 
assumed that in vivo this site is usually phosphorylated. Indeed, when live rats 
were injected with 32P„ the majority of the Rll prepared from brain, heart, and liver 
cytosol was found to be phosphorylated124. Unlike the action of the catalytic 
subunit on exogenous proteins, the phosphorylation of Rll can take place in the 
undisassociated holoenzyme. This reaction is therefore unaffected by cAMP, pro¬ 
tein kinase inhibitor (which acts on free C), or holoenzyme concentration125. The 
autophosphorylation reaction is thought to regulate the activity of Type II CAPK, 
since phosphorylation affects the rate of reassociation between C and Rll126. The 
dephosphorylated form reassociates with C at a rate that is at least five times 
greater than that of phosphorylated Rll (Rll-P). Thus phosphorylation of Rll 

THERTOLYSIN 
GSK3 
CKII 
CAPK(AUTO) 
FIGURE 6: The regulatory subunit of Type II cAMP-dependent protein kinase. 
This diagram of the Rll dimer shows regions susceptible to proteolytic digestion, 
potential phosphorylation sites, the two cAMP binding sites, and the dimerization 
domain. Arrows mark regions susceptible to different proteases. STAPH V8 - 
staphylococcus aureus V8 protease; SER - serine residue; GSK 3 - glycogen 
synthase kinase 3 phosphorylation sites; CK II - casein kinase II phosphorylation 
sites; CAPK(AUTO) - autophosphorylation site of cAMP-dependent protein kinase; 
P - phosphate. 
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prolongs the activity of the kinase. 
There are two mechanisms by which the phosphate group can be removed 
from the autophosphorylated Rll123,124. First, the phosphorylation reaction can be 
reversed in the presence of ADP and Mg2+123. Unlike the forward reaction, this 
reaction demonstrates a pH optimum at pH 5.5. The phosphate group can also 
be removed by phosphatases, including a phosphatase found in bovine cardiac 
muscle127. 
Other phosphorylation sites on Rll 
The autophosphorylation reaction is not the only phosphorylation reaction 
associated with Rll. jn vitro, glycogen synthase kinase 3 (GSK 3) and casein 
kinase II (CK II) can phosphorylate other serine residues, distinct from the serine- 
95 which is autophosphorylated128129. GSK 3 phosphorylates serine-44 and serine- 
47, while CK II phosphorylates serines-74 and 76. The CK II and autophosphoryl¬ 
ation sites can be distinguished with phosphopeptide mapping130. It must be 
recognized that these in vitro phosphorylation activities may not be physiological. 
Instead these reaction may simply reflect a similarity in the amino acid sequence 
of the phosphorylation sites of glycogen synthase and Rll, since C also phosphory¬ 
lates glycogen synthase. However, Rll isolated from rat soleus that had been incu¬ 
bated with “Pi is phosphorylated at the CK II site, indicating that this site is a 
substrate in vivo129. Phosphorylation at the CK II site has no known effect on the 
function of Rll131. However a phosphorylated form of Rll has been found to have 
topoisomerase activity132, although the phosphorylation site responsible for this 
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activity has not been identified. 
The phosphorylation state of Rll has been studied in several systems. In 
smooth muscle from rat trachea, incubation with isoproterenol, a /3-adrenergic 
agonist that increases the cAMP concentration, caused the amount of phospho- 
rylated Rll to decrease133. The direct addition of cAMP to muscle extracts in vitro 
also caused a decrease in phosphorylated Rll’33. A similar dephosphorylation of 
a 55 kDa Rll was seen when cAMP was added to membranes prepared from rat 
liver134. While the phosphorylation site in rat tracheal tissue was not identified, 
phosphopeptide maps of the 55 kDa phosphoprotein described in rat liver 
membranes were identical with those of Rll phosphorylated by CK II. cAMP also 
caused the dephosphorylation of the autophosphorylated CAPK regulatory subunit 
in Blastocladiella emersonii zoospores135. Although zoospores have only one type 
of R, it appears to resemble Rll135. These cAMP-dependent reactions indicate that 
endogenous phosphatases are capable of dephosphorylating Rll. The cAMP- 
dependence of these reactions may indicate that the holoenzyme must disas¬ 
sociate for the phosphate group to be accessible. Alternatively one or more 
phosphatases may be directly or indirectly activated by the presence of cAMP. 
Rll subtypes 
Rll is further distinguished from Rl by the existence of a number of different 
subclasses. As many as six have been identified136, and in at least one instance 
two different forms have been found within the same cell137. Like Rl and Rll, the 
Rll subtypes may be under differential control137. The two forms that have been 
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most extensively studied are referred to as the brain and heart isoforms, Rll-B and 
Rll-H. They were initially distinguished from one another in these tissues by their 
differences in immunoreactivity138,139. It was also observed that autophosphoryla¬ 
tion changes the mobility of Rll-H on SDS-PAGE, whereas that of Rll-B remains 
unchanged140. While the heart subclass is found in most tissues, the neural form 
seems to be more restricted in its distribution. It has been found in ovarian 
tissue141, testis, and adrenal tissue142 as well as brain. The two forms also seem to 
differ in their intracellular distribution. Rll-H is predominately cytoplasmic while Rll- 
B associates with particulate material138. Inspection of the sequences of neural and 
non-neural subtypes has shown that each possesses sites for autophosphorylation 
and phosphorylation by CK II142. However the neural type does not appear to have 
the consensus sequence corresponding to the glycogen synthase kinase 3 phos¬ 
phorylation site142. 
Interactions with other proteins 
Studies undertaken in brain first suggested that Rll might play a role other 
than regulation of CAPK. Previously it was believed that in eukaryotic cells, all 
effects of cAMP were mediated by CAPK98. Thus it was assumed that the cAMP- 
binding proteins Rl and Rll served no other purpose than to inhibit the catalytic 
subunit. However in brain, Rll is found to be tightly associated with microtubule- 
associated protein 2 (MAP 2)143. Neither cAMP nor catalytic subunit inhibit this 
binding, suggesting that it involves a domain that does not interact with cAMP or 
C. In brain, Rll also interacts with a 75 kDa calmodulin-binding protein144, the 
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calmodulin-dependent phosphatase calcineurin169, and an unidentified 80 kDa 
protein145. Rll-binding proteins are also found in heart but appear to be different 
from those found in brain145. 
These Rll binding proteins may serve to fix and compartmentalize CAPK, 
bringing it in close proximity with specific substrates. Alternatively, the interaction 
of Rll with proteins other than C may indicate that Rll serves functions other than 
the regulation of the kinase. The latter hypothesis is consistent with evidence 
suggesting that in some cells free Rll exists in excess of C'18. In either case it is 
plausible that Rll may be involved in cytoskeletal regulation. Not only does Rll 
associate with MAP-2, a protein found in close proximity to microtubules; immuno- 
cytochemistry localized Rll to microtubules, microtubule-organizing centers, and 
parts of the Golgi complex146. This association with the cytoskeleton is of particular 
relevance in the evaluation of the role of Rll in the parietal cell, since the 
cytoskeleton is thought to be critically involved in the morphological transforma¬ 
tion associated with secretion. 
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CHAPTER 3 
MATERIALS AND METHODS 
MATERIALS 
New Zealand white rabbits (2-3 kg) were obtained from Camm (Wayne, NJ). 
Pronase (Protease E), collagenase (type I), histamine chloride, CAPK catalytic 
subunit, kemptide, heat stable CAPK inhibitor from rabbit muscle (Product No. P 
5015), and CAPK pseudosubstrate (Product No. P3294) were purchased from 
Sigma Chemical Co. (St. Louis, MO). Forskolin was purchased from Calbiochem 
(La Jolla, CA). Cimetidine was obtained from SmithKIine and French (Philadelphia, 
PA). [14C]aminopyrine was obtained from Amersham (Arlington Heights, IL). 
[gamma 32P]-ATP (5-10 Ci/mmol) was purchased from New England Nuclear 
(Boston, MA). [125l]-goat anti-mouse IgG and 8-azido-[32P]-cAMP were purchased 
from ICN (Costa Mesa, CA). Calmodulin was produced from bovine brain by Dr. 
James Goldenring (Yale University, New Haven, CT) using the method of 
DeLorenzo and Goldenring147. Molecular weight markers, carbamylated isoelec¬ 
tric focusing standards, and Protein A beads were products of Pharmacia (Pis- 
cataway, NJ). Immobilon P was purchased from Millipore (Bedford, MA). Cyclic 
AMP assay kits were bought from Diagnostic Products Corporation (Torrance, CA). 
Okadaic acid was a gift from Dr. Harold Rasmussen (Yale University, New Haven, 
CT). A monoclonal antibody against the gastric H'/K-ATPase was the gift of Dr. 
Adam Smolka (University of South Carolina, Charleston, SC). The monoclonal 
antibodies 6H11, 2E11, and 4A5 against the 80 kDa parietal cell apical membrane 
protein were the gift of Dr. John Forte (University of California, Berkeley, CA). 
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Polyclonal antibodies against rat heart and rat brain Rll were the gift of Dr. 
Suzanne Lohmann and Dr. Ulrich Walter (University of Wurzburg, West Germany) 
and Dr. Pietro DeCamilli (Yale University, New Haven, CT). All other reagents were 
from standard suppliers and were of the highest purity available. 
PREPARATION OF CELLS 
Parietal cells were prepared by a modification of techniques described for 
isolation of gastric glands25 and parietal cells42148 149. After high pressure aorto- 
celiac perfusion, fundic mucosa was bluntly separated from submucosa. Mucosal 
fragments were digested for 20 min at 37 °C under 100% 02 with 0.5 mg/ml 
pronase in 50 ml of solution 1 (130 mM NaCI; 12 mM NaHC03; 3 mM NaH2P04; 
3 mM Na2HP04; 3 mM I^HPO,; 2 mM MgS04; 1 mM CaCI2; 0.03 mM bovine serum 
albumin (fraction V) (BSA); 11 mM dextrose; and phenol red, 10mg/l, pH 7.4). 
After collagenase digestion the tissue was washed three times by pelleting and 
resuspension in solution 2 (132.4 mM NaCI; 5.4 mM KCI; 5 mM Na2HP04; 1 mM 
NaH2P04; 1.2 mM MgS04; 1 mM CaCI2; 0.5 mM dithiothreitol (DTT); 1 mM pyru¬ 
vate; 10 mM HEPES (N-2-hydroxyethylpiperazine-N’-2-ethanesulfonicacid) pH 7.4; 
0.06 mM BSA; 10 mM dextrose; and phenol red 10mg/l). After washing, the tissue 
was resuspended in 50 ml of solution 1 containing collagenase 0.8 mg/ml and 
allowed to incubate for 45 min at 37 °C under 100% 02. DNAse 0.5 mg/ml was 
added for the last ten minutes. Dispersed cells were then washed three times in 
solution 2, filtered through 30 mm nylon mesh and resuspended in 10 ml of solution 
2. 
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The cells were then fractionated on discontinuous Nycodenz gradients. 
These were prepared in the following manner: isotonic sterile Nycodenz solution 
containing 0.06 mM BSA was diluted 1:1 (density 1.075 g/ml) and 1:2 (density 
1.050 g/ml) with diluent solution (5 mM Tris-HCI, pH 7.4; 3 mM KCI; 0.3 mM CaNa- 
EDTA; 128.3 mM NaCI; and 0.06 mM BSA). Gradients were prepared by placing 
5 ml of the 1:1 solution below 8 ml of the 1:2 solution. Two ml of the cell suspen¬ 
sion were layered on top of each gradient, which was then centrifuged at 200 x g 
for 10 min at 10 °C. Enriched parietal cells (purity 85 ± 5%) were removed from 
the interface between the 1.075 g/ml and the 1.050 g/ml solutions. These cells 
were washed three times by pelleting and resuspension in solution 2. Solution 2 
was then used to bring the cells to the desired concentration. All steps used a 
Beckman J6M refrigerated centrifuge. 
PREPARATION OF SUBCELLULAR FRACTIONS 
Purified parietal cells were resuspended in solution 2 to a concentration of 
5 x 10s cells/ml. After a 10 min recovery period at 37 °C under 100% 02, cells 
were incubated for 45 min more with either 100 mM cimetidine (unstimulated cells) 
or 100 juM histamine plus 10 ^M forskolin (maximally stimulated cells). Subcellular 
fractions were then prepared using a modification of the method developed for 
gastric glands by Urushidani et aL75. 
Cells were pelleted at 50 x g for 5 min at 4 ° C. Homogenization buffer (110 
mM mannitol; 10 mM sucrose; 150 mM NaCI; 1 mM MgCI2; 5 mM benzamidine; 
1 mM PMSF; 1 /uM aprotonin; and 1 ^M leupeptin) was added to the cell pellets 
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(0.5 ml/million cells), which were then homogenized on ice with 15 strokes of a 
Potter-Evelyn homogenizer at 900 rpm. Subcellular fractions were then prepared 
by differential centrifugation (Figure 7). Cell homogenates were first centrifuged 
for 5 min at 40 x g to make the P0 pellet. The supernatant from this pellet was then 
centrifuged for 10 min at 4000 x g to make the P, pellet. The supernatatant was 
again centrifuged, this time for 10 min at 14,500 x g to make the P2 pellet. Finally, 
the remaining supernatant was spun once more at 48,500 x g for 60 min to 
produce the P3 pellet and the final, high-speed S3 supernatant. All centrifugation 
was conducted at 4°C. Pellets were washed with homogenization buffer and 
resuspended in resuspension buffer (200 mM sucrose, 100 mM NaCI, and 0.5 mM 
EDTA). Low speed centrifugation was undertaken in a Beckman J6M refrigerated 
centrifuge, while the final high-speed spin required a Sorvall OTD-2 ultracentrifuge. 
CHARACTERIZATION OF SUBFRACTIONS 
Immunoblotting 
Western blotting was used to determine the distribution of the H7K+-ATPase 
and the 80 kDa apical membrane protein77. Samples of both stimulated and 
unstimulated subcellular fractions were resolved on 10% SDS-PAGE minigels and 
transferred to Immobilon overnight at 50 milliamps150. Blots were blocked with 
Blotto (5% non-fat dry milk; 0.1% Triton X-100; 25 mM Tris HCI, pH 7.5; and 150 
mM NaCI) for two hours. The blots were then incubated overnight with either a 
monoclonal antibody directed against the H'/IC-ATPase (1:150 dilution) or a 
mixture of three monoclonal antibodies against the 80 kDa protein (1:100 dilution). 
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FIGURE 7: Protocol for preparation of subcellular fractions. 
Differential centrifugation was used to prepare subcellular fractions from homoge 
nized parietal cells. For a more detailed description, see text. (P - pellet; S - super 
natant). 
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After this incubation, blots were washed 3 times in Blotto, then incubated with [125l]- 
goat anti-mouse IgG for 2 hours. The blots were then washed 3 more times with 
Blotto before drying. 
Dried blots were exposed to x-ray film to locate the bands of interest. The 
data were quantified by cutting out the labeled bands and counting them in a 
gamma counter. Data were then expressed as cpm/mg total protein in the original 
sample. 
Cyclic AMP-dependent protein kinase activity 
CAPK activity was determined using kemptide102, a synthetic substrate 
peptide for CAPK. Prior to assay, membrane fractions were solubilized in 0.5% 
Triton X-100 for 30 min on ice. In the final reaction mixture, the Triton was diluted 
to 0.04%. Cytosolic fractions were used without any further preparation. The 
standard 50 /xl reaction mixture contained 5 kemptide; 25-50 jug protein sample; 
50 mM HEPES, pH 7.0; 10 mM MgCI2; and 100 /uM [gamma-32P]-ATP (100-400 
cpm/pmol). Reactions were also performed in the absence of kemptide. Another 
set of reactions was performed in the presence of 10 mM cAMP. All reactions were 
allowed to proceed at 35 °C for 30 min. After 30 min, four 10 n\ samples were 
withdrawn from each reaction tube and spotted on 2 x 1 cm pieces of Whatman 
P81 paper. This is a basic paper that binds the positively charged kemptide. Free 
ATP was then removed by washing the pieces of paper 4 times for 10 min each 
in 50 mM phosphoric acid. After an acetone rinse, papers were then dried and 
Cherenkov radiation counted. The phosphorylation of kemptide was determined 
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by subtracting the amount of bound radioactivity seen in the presence of sample 
alone from that seen in the presence of kemptide. 
Other parameters 
To quantify the presence of nuclear material in subcellular fractions, DNA 
content was determined using the method of West et aL151. Fractions were also 
evaluated for the presence of mitochondria using cytochrome C oxidase activity 
as a marker. Cytochrome C oxidase activity was determined by the method of 
Peters et aL152. Protein content of each fraction was determined by the method of 
Bradford153, using BSA as a standard. 
IN VITRO PHOSPHORYLATION 
]n vitro phosphorylation of endogenous proteins in subcellular fractions was 
assayed using 10 /xl of protein sample in a reaction volume of 100 /xl. The 
standard reaction mixture contained 50 mM HEPES (pH 7.0), 10 mM MgCI2, 0.5 
mg/ml DTT, and 10 /xM [gamma-32P]-ATP. Reactions were carried out in both 
the presence and absence of 10 /xM cAMP. Reactions were initiated by the 
addition of [gamma-32P]-ATP and were allowed to proceed for 60 sec at 35 °C. 
Reactions were stopped by the addition of 50 /xl of 3% SDS stop solution followed 
by boiling for 5 min. After the samples cooled, 20 /xl of 2-mercaptoethanol was 
added to each sample prior to loading for SDS-PAGE. 
The standard reaction mixture was varied by changing the concentration of 
Mg2+ (0.1 mM to 30 mM), ATP (0.1 /xM to 50 /iM), and cAMP (0.1 nM to 10 /xM). 
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A time course of the standard reaction was performed by stopping the reactions 
at times from 5 sec to 5 min. To determine whether the kinase could also use 
GTP as a substrate, in some experiments GTP (0.1 mM to 50 mM) was substituted 
for ATP. To determine whether cAMP had a unique effect on the phosphorylation 
reaction, cyclic GMP (0.01 /zM to 10 mM) was substituted for cAMP in some 
experiments. The pH of the reaction was varied by using MES and HEPES buffers 
ranging from pH 5.5 to pH 8.0. Reactions were also carried out in the presence 
of the heat stable CAPK inhibitor (1 Mg/ml), CAPK pseudosubstrate (0.2 units/jul), 
CAPK catalytic subunit (0.1 units//zl), calmodulin (0.01 mg/ml), CaCI2 (1 mM), 
MnCI2 (10 mM), ZnS04 (10 mM), or EDTA (2 mM; exogenous MgCI2 was not 
added to the reaction containing EDTA). 
To evaluate the presence of a phosphatase in the P,, standard in vitro 
phosphorylation reactions were stopped after 60 sec with 10 mM EDTA. cAMP 
was immediately added and the reaction was then stopped at various time points 
from 0 sec to 4 min with 50 /zi of 3% SDS stop buffer. The dephosphorylation 
seen in the presence of 10 /zM cAMP was evaluated by observing the effect of 
known phosphatase inhibitors including MnCI2 (10 mM), ZnS04 (10 mM), NaF (50 
mM), pyrophosphate (10 mM), and okadaic acid (0.01 /iM to 10 mM). At the end 
of standard 1 min phosphorylation reactions, 10 mM EDTA was added to stop 
further phosphorylation. Potential phosphatase inhibitors were then added to the 
reaction mixture with 10 /zM cAMP. Reactions were allowed to run for 3 min more 
before being stopped with 1% SDS. 
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PHQSPHOAMINO ACID ANALYSIS 
Phosphoamino acid analysis was performed on phosphoproteins separated 
on either one- or two-dimensional gels using a previously described modification 
of the method of Hunter and Sefton154,155. This method allows separation of all 
three stable phosphoamino acid species: phosphoserine, phosphothreonine, and 
phosphotyrosine. 
8-AZIDO-cAMP BINDING STUDIES 
Subcellular fractions were assayed for cAMP-binding proteins using 8-azido- 
[32P]-cAMP, a photoaffinity probe which binds competitively at cAMP-binding sites. 
Upon excitation with ultraviolet light, this compound generates a free radical that 
inserts into a carbonyl bond, thus binding it irreversibly to the substrate protein. 
Reaction mixtures (90 nI) containing 50 mM HEPES, pH 7.0; 0.1 mM IBMX; 
10 mM MgCI2; and 50-100 ^g of the protein sample were prepared in a microtiter 
plate and placed on ice. In semi-darkness 10 n\ of 8-azido-[32P]-cAMP was added 
to each reaction. Control reactions contained in addition 100 juM nonradioactive 
cAMP, After mixing, the microtiter plate was wrapped in foil, placed on ice, and 
incubated on a rocker platform for 30 min. The plate was then unwrapped and 
exposed to a high power UV light (XXI5, Ultra-Violet Products Inc.) at 6 inches for 
5 min. Reactions were then stopped by the addition of 3% SDS stop solution (1% 
SDS final concentration) or isoelectric focusing stop solution (see Methods: Two- 
dimensional gel electrophoresis). This allowed samples to be resolved by one- 
or two- dimensional gel electrophoresis. 
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IMMUNQPRECIPITAT1QN 
Standard 100 jul phosphorylated reaction mixtures were used. After being 
stopped by the addition of SDS to a final concentration of 1% and boiling, samples 
were diluted 1:9 with RIPA156 buffer (150 mM NaCI, 10 mM Tris HCI, pH 7.4, 10 
mM sodium pyrophosphate, 20 mM NaF, 1 mM EDTA, 1% sodium deoxycholate, 
and 1% Triton X-100) with 0.5 mg/ml BSA and 5 mM benzamidine. Polyclonal 
antisera against rat heart Rll and rat brain Rll were used to immunoprecipitate 
these samples. Five jul of undiluted antiserum, 5 jul of non-immune rabbit serum, 
or 5 /xl of RIPA were then added to each sample. Reaction mixtures were then 
incubated overnight at 4°C with constant agitation. Immune complexes were 
immunoprecipitated by incubation for 2 hours with 3 to 5 mg of pre-swollen Protein 
A-sepharose beads. The beads were pelleted for 5 min at 1000 x g, then washed 
three times in RIPA with 0.5 mg/ml BSA and 0.1% SDS, followed by two washes 
with RIPA alone. The washed beads were boiled for 5 min in 100 fi\ of 1% SDS 
stop solution to remove the adherent proteins. The beads were then pelleted and 
the supernatants collected for SDS-PAGE resolution. 
WHOLE CELL STUDIES 
Measurement of acid secretion 
Acid secretion was assessed by the semi-quantitative uptake of [14C]amino- 
pyrine (AP) using a modification of the method of Berglindh157 28. A parietal cell 
suspension containing 1.5x106cells/ml in solution 2 was pre-incubated with 2.12 
nmol/ml [14C]AP (specific activity 4.366 Bq/nmol) for 30 min at 37 °C under 100% 
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02. Following pre-incubation, 100 nI aliquots (150,000) cells were added to 96 well 
microtiter plates with integral durapore (Millititer SV) membrane filters (5.0 pore 
size). 
Cells were then incubated with okadaic acid (concentration 0.01 mM to 3 
jizM), the CAPK inhibitor H-8 (concentration 0.01 mM to 30 juM), or control (an equal 
volume of solution 2). Each condition was performed in triplicate. The plates were 
then placed in an oxygenation chamber and oxygenated at 370 C for 30 minutes’53. 
At the end of this time period histamine (10 *xM) was added. In some okadaic 
acid experiments, a combination of histamine (100 juM) and forskolin (10 mM) was 
used instead. Cells were then incubated for an additional 45 min in the presence 
of 100% 02 at 37 °C. At the end of this incubation period cells were rapidly sepa¬ 
rated from incubation media by vacuum filtration. The membrane filters containing 
the cells were dried, punched into scintillation vir's, and counted in a liquid scintilla¬ 
tion counter. Non-specific binding of [,4C]AP to membrane filters was measured 
in wells containing an equal amount of isotope but no cells. This non-specific 
binding was subtracted from binding measured in the presence of cells. Data were 
then expressed as a percentage of maximal [14C]AP uptake. 
Measurement of cAMP concentration 
Cyclic AMP was assayed using a commercial assay kit (Diagnostic Products 
Corp.). Parietal cells were incubated in the same manner used for the secretion 
assay. Each condition was performed in duplicate. After vacuum filtration, the 
membrane filters containing the cells were punched into tubes containing 0.5 ml 
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ice-cold 3% perchloric acid, vortexed for 20 sec, and stored at -70 °C until assay. 
Immediately prior to assay samples were thawed and stored on ice before adding 
100 ii\ of cold 30% KHC03, bringing the pH to 6.0. The samples were centrifuged 
and 100 ill of supernatant was assayed for cAMP by competitive protein binding 
assay158. Results were expressed as pmol/106 cells. 
GEL ELECTROPHORESIS 
One-dimensional SDS-PAGE 
Proteins were resolved using a modification of the method of Laemmli159. 
Discontinuous sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS- 
PAGE) was performed using 10% separating gels with 4% stacking gels cast on 
Gelbond PAG film. After electrophoresis, the gels were stained with Coomassie 
blue, dried in a forced air oven at 60 °C, and exposed to x-ray film (Kodak XAR- 
5) at -700 C for 8 to 120 hours. Molecular weights were determined using standard 
protein molecular weight markers. 
Two methods were used to quantify protein phosphorylation. In some 
cases, a Biorad densitometer was used to measure the optical density of 
phosphorylated bands detected by autoradiography. Alternatively, 32P incorpora¬ 
tion was determined by excising bands from dry gels. The radioactivity of the 
band was then measured using a liquid scintillation counter. In each method, data 
were expressed as a percentage of maximal phosphorylation. 
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Two-dimensional gel electrophoresis 
Proteins were separated on two-dimensional isofocusing/SDS-PAGE using 
a modification of the method of O’Farrelf60. Samples were prepared by adding an 
equal volume of isoelectric stop buffer (4% Triton X-100; 4% 3-10 ampholines; 10% 
2-mercaptoethanol; 9.5 M urea). Isoelectric focusing in the first dimension was 
accomplished in polyacrylamide tube gels using 3 to 10 ampholines (4%). In the 
second dimension, proteins were separated by SDS-PAGE, as described above. 
After electrophoresis, the gels were handled in the manner described for one¬ 
dimensional gels. Isoelectric points were determined using carbamylated 
standards. 
STATISTICAL METHODS 
Measurements of [14C]aminopyrine accumulation and cAMP levels were 
compared to controls using a t-test for paired samples. 
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CHAPTER 4 
RESULTS 
Previous studies using isolated rabbit parietal cells have shown that 
histamine stimulates the accumulation of [14C]aminopyrine, a marker for parietal cell 
acid secretion157 (Figure 8). Histamine stimulation also results in an increase in the 
intracellular concentration of the second messenger cAMP157 (Figure 8). The only 
known function of cAMP is activation of the cAMP-dependent protein kinase58, 
which phosphorylates a wide variety of substrate proteins97. Several groups have 
identified a number of histamine-stimulated phosphoproteins in rabbit parietal cells 
and gastric glands72 73 74 75. We hypothesized that histamine stimulation might 
change the phosphorylation state of proteins found in actively secreting parietal 
cells. If such proteins were found, they would be likely intermediaries in histamine- 
stimulated acid secretion. By preparing subcellular fractions from homogenized 
cells we hoped to be able to localize phosphorylation changes to specific intracel¬ 
lular compartments. 
Subcellular fractions prepared from resting and stimulated parietal cells were 
therefore characterized. These fractions were then assayed for kinase activity. 
This survey revealed that the apical membrane-rich fraction in stimulated parietal 
cells possesses both kinase and phosphatase activities that act on a 52 kDa 
protein substrate. The protein was identified as the regulatory subunit of Type II 
CAPK (Rll). Whole cell secretion studies were then undertaken using a phospha¬ 
tase inhibitor and an inhibitor of CAPK, to determine whether the kinase or a 
phosphatase played the key role in parietal cell acid secretion. 
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FIGURE 8: Effect of histamine stimulation of isolated rabbit parietal cells on 
fuC1aminopyrine uptake and cellular cAMP content. 
Isolated rabbit parietal cells were incubated with histamine (10 /xM). [,4C] 
aminopyrine accumulation and cellular cAMP content were measured as described 
in Chapter 3. Top panel: time course of [,4C]aminopyrine uptake. Bottom panel: 
time course of cellular cAMP content. 
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CHARACTERIZATION OF SUBFRACTIONS 
When Urushidani and Forte characterized subtractions prepared from rabbit 
gastric glands, they used IC-p-nitrophenyl phosphatase as a marker for H+/K+- 
ATPase activity7'. They reported that in resting glands, the bulk of the activity was 
present in the microsomal P3 fraction. However in histamine-stimulated glands, the 
activity in P3 decreased by 50%. This decrease was accompanied by a striking in¬ 
crease in activity in the apical membrane-rich P, fraction 75. This data supported 
the hypothesis that in the stimulated cell, the H YK+-ATPase moves from the lighter 
tubulovesicles to the heavier apical membrane. The same group has also des¬ 
cribed an 80 kDa actin-binding protein that additionally serves as a marker for the 
apical membrane77. Histamine stimulation changed the phosphorylation state of 
this protein without altering its subcellular distribution. 
In our preparation, made from isolated rabbit parietal cells rather than 
glands, we used a monoclonal antibody against the H+/K+-ATPase to localize the 
proton pump and characterize the subcellular fractions. In agreement with pre¬ 
vious studies, we found that in histamine-stimulated cells the H */K+-ATPase moved 
from the microsomal P3 fraction to the heavier P0 and P, (Figure 9). These 
fractions, but particularly P,, in both resting and stimulated cells, also showed 
enriched immunoreactivity with a monoclonal antibody against the 80 kDa actin- 
binding protein described above (Table III). The presence of these markers in the 
P, subcellular fraction is consistent with the conclusion that the P, fraction was 
enriched with apical membrane. The P0 fraction exhibited somewhat similar cha¬ 
racteristics, but had the highest DNA content (Table III), indicating the additional 
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FIGURE 9: Distribution of the HVKf-ATPase in subcellular fractions prepared from 
parietal cell homogenates. 
Western blot analysis was used to study the distribution of the H+/K+-ATPase in 
subcellular fractions from maximally stimulated and unstimulated parietal cells. 
SDS-PAGE was used to resolve proteins from all subcellular fractions from both 
unstimulated (V) and maximally stimulated (S) cells (15 ng of protein per sample). 
Western blot analysis was then performed as described in Chapter 3, using a 
monoclonal antibody against the H "/IC-ATPase. PO, PI, P2, P3 - membrane frac¬ 
tions; S3 - cytosolic fraction; V - unstimulated; S - maximally stimulated; H/K - 
H+/K"-ATPase. 
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VP0 SP0 VPi SPi VP2 SP2 VP3 SP3 vs3 ss3 
DNA (pg/mg protein) 115 128 52 38 11 11 15 13 34 21 
Cytochrome C 
Oxidase (A545 
units/mg protein) 
140 130 180 165 75 42 3 4 0 0 
80 kDa 
immunoreactivity 
(cpm/mg protein) 
2000 2100 6000 5600 1000 900 150 200 0 0 
cAMP-dependent 
kinase (pmol/mg 
prot/min) 
2.3 3.3 0.8 1.5 6.2 12.5 24.3 17.0 713 280 
TABLE III: Characterization of subcellular fractions. 
All fractions in both stimulated and unstimulated cells were assayed for DNA 
content, cytochrome C oxidase activity, 80 kDa protein immunoreactivity, and 
cAMP-dependent protein kinase activity. Unstimulated cells were treated with 
cimetidine (100 /iM). Stimulated cells were treated with histamine (100 ^M) and 
forskolin (10 mM). For materials and methods see Chapter 3. V - unstimulated; S - 
stimulated; P0, P„ P2, and P3 - membrane fractions; S3 - cytosolic fraction. 
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presence of nuclear material. The P, fraction was slightly enriched in DNA. 
Cytochrome C oxidase activity, a mitochondrial marker, was enriched in the P0 and 
P, fractions (Table III). From these data it was concluded that the P, fraction is the 
apical membrane-rich fraction, although it also contains some nuclear and 
mitochondrial contaminants. 
IN VITRO PROTEIN PHOSPHORYLATION IN SUBCELLULAR FRACTIONS 
Endogenous phosphorylation was assayed in all subcellular fractions 
prepared from both resting and stimulated parietal cells (Figure 10) in the presence 
and absence of cAMP. In the presence of 10 mM Mg2+ and 10 mM ATP, many 
proteins were phosphorylated in all fractions. However the most prominent and 
consistent findings were observed in the P, apical membrane fraction and the S3 
cytosolic fraction (Figure 11). 
In the stimulated P, a protein with the molecular weight of 52 kDa (pp52) 
was phosphorylated in the absence of cAMP. The time course of this activity was 
extremely rapid, reaching maximal phosphorylation within 45 sec at 35°C (Figure 
12). The phosphorylation of pp52 was dependent on the concentration of Mg2+ 
(Figure 13) and could be eliminated entirely by EDTA. The activity was also 
dependent on the concentration of ATP (Figure 14), with a K/2 for ATP of approxi¬ 
mately 3 nM. Although the kinase could use GTP as a substrate (K./, 10 /xM) 
(Figure 14), it exhibited a preference for ATP. The kinase did not exhibit a pH op¬ 
timum; phosphorylation took place over a pH range from 5.5 to 8.0. Phospho¬ 
rylation was not affected by the presence of the heat-stable CAPK inhibitor, CAPK 
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FIGURE 10: Autoradiograph showing endogenous phosphorylation in all 
subcellular fractions. 
Standard 1 min in vitro phosphorylation reactions were performed with and without 
10 cAMP ( + /- cA) using protein samples from homogenate (HOM) and 
subcellular fractions P0 through S3. Unstimulated (V) cells were treated with cime- 
tidine 100 juM. Maximally stimulated (S) cells were treated with histamine (100 juM) 
and forskolin (10/iM). Samples were resolved using SDS-PAGE and autoradio¬ 
graphy. Molecular weight standards are indicated on the left. Arrows show the 
position of the 52 kDa phosphoprotein (pp52). 
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FIGURE 11: Autoradiograph showing endogenous phosphorylation in the apical 
membrane fraction and the cytosolic fraction. 
Standard 1 min in vitro phosphorylation reactions were performed with and without 
10 mM cAMP ( + /- cA) using protein samples from the P, membrane fraction and 
the cytosolic S3 fraction (S3). Unstimulated (V) cells were treated with cimetidine 
(100 mM). Maximally stimulated (S) cells were treated with histamine (100 ^M) and 
forskolin (10 mM). Samples were resolved using SDS-PAGE and autoradiography. 
Arrows indicate the position of the 52 kDa phosphoprotein. 
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FIGURE 12: Time course of po52 phosphorylation, 
Standard in vitro phosphorylation reactions were performed using protein samples 
from the maximally stimulated P, membrane fraction. Reactions were stopped at 
time points from 5 sec to 300 sec. Samples were resolved by SDS-PAGE and 
autoradiography, and phosphorylation of pp52 was quantified as described in 
Chapter 3. Phosphorylation was maximal by 120 sec; therefore time points 
beyond 120 sec are not shown. 
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FIGURE 13: Magnesium dependence of pp52 phosphorylation. 
Standard 1 min in vitro phosphorylation assays were performed using protein 
samples from the maximally stimulated P, membrane fraction. However the 
concentration of exogenous Mg2+ was varied from 0.1 mM to 30 mM. Samples 
were resolved with SDS-PAGE and autoradiography, and the phosphorylation of 
pp52 was quantified as described in Chapter 3. Phosphorylation is expressed here 
as percent maximal phosphorylation. Phosphorylation was maximal at 10 mM; 
therefore values for higher Mg*+ concentrations are not shown. 
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FIGURE 14: ATP and GTP dependence of pp52 phosphorylation. 
Standard 1 min. in vitro phosphorylation reactions were performed using protein 
samples from the maximally stimulated P, membrane fraction. Either [gamma- 
“Pj-ATP or [gamma-^PJ-GTP was used as a phosphate donor with concentrations 
ranging from 0.1 *iM to 50 mM. Samples were resolved using 1-D SDS-PAGE and 
autoradiography, and phosphorylation of pp52 was quantified as described in 
Chapter 3. Phosphorylation is expressed here as percent maximal phosphoryla¬ 
tion. Closed circles represent the phosphorylation of pp52 in reactions using GTP. 
Open squares represent the phosphorylation of pp52 in reactions using ATP. 
Phosphorylation was negligible for concentrations of ATP and GTP less than 1 /iM; 
these values are not shown. 
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pseudosubstrate or CAPK catalytic subunit. This suggested that the kinase activity 
was not dependent on CAPK. Calcium, calmodulin, manganese, and zinc also had 
no effect on the phosphorylation of pp52. Surprisingly, the addition of cAMP 
decreased the phosphorylation of pp52 in a concentration-dependent fashion 
(Figure 15). When cGMP was substituted for cAMP, this effect was not seen. 
A 52 kDa protein was also noted to be phosphorylated in the cytosolic S3 
fraction (Figure 11). In contrast to the phosphorylation seen in the apical 
membrane-rich P, fraction, this phosphorylation was observed in both stimulated 
and unstimulated S3 fractions, but was more evident in the unstimulated samples. 
This kinase activity also differed from that seen in the P, fraction in its cAMP 
dependence. Whereas the apical membrane pp52 was phosphorylated in a cAMP- 
independent fashion and dephosphorylated in a cAMP-dependent manner, the 
phosphorylation of the cytosolic pp52 required cAMP. The heat-stable CAPK 
inhibitor and CAPK pseudosubstrate inhibited phosphorylation of the cytosolic 
pp52, suggesting that this activity was mediated by the catalytic subunit of CAPK. 
The cytosolic activity also differed from the apical membrane activity in that there 
was no evidence of endogenous dephosphorylation in the S3 fraction. These 
differences suggest either that histamine has different effects on the same protein 
when it is found in different intracellular compartments or that the 52 kDa proteins 
found in the membrane and cytosol are two different proteins. 
The phosphorylation of the 52 kDa apical membrane protein in vitro 
suggests that in vivo this protein is actually dephosphorylated by histamine 
stimulation (Figure 16). If histamine stimulation removes a phosphate from a 
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FIGURE 15: The cAMP-dependent dephosphorvlation of pp52. 
Standard 1 min in vitro phosphorylation reactions were performed in the presence 
of cAMP (0.1 nM to 10 /xM) using protein samples from the maximally stimulated 
P, membrane fraction. Samples were then resolved using SDS-PAGE and 
autoradiography, and the phosphorylation of pp52 was quantified as described in 
Chapter 3. Phosphorylation is expressed here as percent maximal phosphoryla¬ 
tion. 

HISTAMINE 
FIGURE 16: The relationship of phosphorylation changes in vivo to phosphoryla¬ 
tion changes observed in vitro. 
In the resting parietal cell, protein A (gray square) is phosphorylated and protein 
B (black circle) is not. Histamine stimulation causes the dephosphorylation of 
protein A and the phosphorylation of protein B with endogenous phosphate (P). 
The cells are then homogenized. Standard phosphorylation reactions as described 
in Chapter 3 are performed on the homogenates. Only the dephosphorylated pro¬ 
tein A can undergo phosphorylation with the radioactively labelled phosphate (KP). 
When the sample is resolved using SDS-PAGE and autoradiography, only protein 
A is detected as a phosphoprotein. Thus the histamine-stimulated dephospho¬ 
rylation of protein A in vivo is detected as an increase in phosphorylation in vitro. 
Conversely, an increase in phosphorylation in vivo is detected as a decrease in 
vitro. 
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protein, when homogenates are prepared and subjected to in vitro phosphoryl¬ 
ation, the empty phosphorylation site will be able to accept a phosphate group. 
In contrast, a site that is already phosphorylated with native phosphate will not 
undergo further phosphorylation with 32Pr Thus the histamine-stimulated 
dephosphorylation of a protein in vivo is detected as an increase in phosphoryla¬ 
tion in the homogenate. Conversely, a histamine-stimulated increase in phos¬ 
phorylation in vivo is detected as a decrease in vitro. 
The dephosphorylation of apical membrane pp52 observed in the presence 
of cAMP was somewhat unexpected, since cAMP is known to activate CAPK and 
thus protein phosphorylation. Further experiments demonstrated that the addition 
of cAMP activated a phosphatase in the stimulated apical membrane fraction. 
When cAMP was added to the reaction mixture at the end of the one minute 
phosphorylation reaction, pp52 was completely dephosphorylated within two min¬ 
utes (Figure 17). This effect of cAMP was not inhibited by common phosphatase 
inhibitors such as Zn2+, Mn2+, NaF and pyrophosphate. However it was inhibited 
by the phosphatase inhibitor okadaic acid161 in a concentration-dependent fashion 
(Figure 18). The ID^ for okadaic acid was approximately 0.3 jixM. This sensitivity 
to okadaic acid is most consistent with a Type 1 phosphatase activity162. 
IDENTIFICATION OF PP52 
Several lines of investigation suggested that both the cytosolic and the 
apical membrane forms of pp52 could be identified as the regulatory subunit of 
Type II cAMP-dependent protein kinase (Rll). These included isoelectric focusing, 
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FIGURE 17: Time course of cAMP-dependent deohosohorvlation of pp52 in the 
stimulated apical membrane fraction. 
Standard 1 min in vitro protein phosphorylation reactions were performed using 
protein samples from the maximally stimulated P, membrane fraction. At the end 
of one min 10 mM EDTA was added to stop further phosphorylation. Reactions 
were then allowed to continue for 0 to 240 sec more in the presence or absence 
of 10 mM cAMP. Samples were then resolved using SDS-PAGE and autoradio¬ 
graphy and the phosphorylation of pp52 was quantified as described in Chapter 
3. Phosphorylation is expressed as percent maximal phosphorylation. The time 
points indicated above were measured from the end of the 1 min reaction. Open 
squares represent the phosphorylation of pp52 in the absence of cAMP. Closed 
circles represent the phosphorylation of pp52 in the presence of cAMP. Beyond 
120 sec there was no detectable phosphorylation of pp52 in the presence of 
cAMP; therefore this data is not shown. 
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FIGURE 18: Autoradiograph showing the effect of the phosphatase inhibitor 
okadaic acid on the cAMP-deoendent deohosphorvlation of pp52. 
Standard 1 min in vitro phosphorylation reactions were performed using protein 
samples from the maximally stimulated P, fraction. At one min 10 mM EDTA was 
added to stop further phosphorylation. At that time CAMP (10 /uM) and okadaic 
acid (1 nM to 10 /xM) were added to the reactions, which were allowed to proceed 
for 3 min more. Samples were then resolved using SDS-PAGE and autoradio¬ 
graphy. cA + /- indicates the presence/absence of 10 mM cAMP. The concen¬ 
tration of okadaic acid in each sample is indicated at the top of each lane. The 
arrow labelled Rll marks the location of pp52. 
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phosphoamino acid analysis, cAMP-binding, and immunoreactivity. Two-dimen¬ 
sional gel electrophoresis showed that both the membrane and cytosolic forms of 
pp52 had isoelectric points of approximately 5.0 (Figure 19), comparable to 
published values for Rif63 139. Phosphoamino acid analysis of the membrane and 
cytosolic forms of pp52 was also consistent with the conclusion that these proteins 
are both Rll. While Rll can be phosphorylated at several sites, the only amino 
acids that are phosphorylated are serine residues. Similarly, phosphoamino acid 
analysis showed that pp52 in both membrane and cytosol is phosphorylated on 
serine residues. 
Both forms of pp52 were found to be cAMP-binding proteins. Mammalian 
cells are believed to contain only two cAMP-binding proteins: the regulatory 
subunits of Type I and Type II CAPK164. 8-azido-[32P]-cAMP binding was used to 
assay subcellular fractions for cAMP-binding proteins. The P, and S3 fractions 
each contained two major cAMP-binding proteins (Figure 20). The first, which 
focused as a doublet of approximately 49 kDa, was identified as Rl on the basis 
of its electrophoretic mobility. Maximal stimulation of parietal cells with histamine 
and forskolin abolished 8-azido-cAMP binding to this protein. This finding is 
consistent with results published by Chew71, who interpreted it as evidence for the 
stimulation of Type I CAPK. Since the secretagogues induce an increase in 
intracellular cAMP, this endogenous cAMP is presumably bound to Rl, thus 
preventing 8-azido-cAMP binding and liberating free catalytic subunit. Both P, 
and S3 also contained cAMP-binding proteins with molecular weights of 52 kDa. 
Since the molecular weights, as determined by SDS-PAGE, and the isoelectric 
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FIGURE 19: Autoradiograph of a two-dimensional ael showing protein phosphory¬ 
lation in stimulated apical membrane and unstimulated cytosolic fractions. 
Standard 1 min in vitro phosphorylation reactions were performed using protein 
samples from maximally stimulated apical membrane fractions (SP,) and 
unstimulated cytosolic fractions (VS3). The phosphorylated samples were then 
resolved using 2-D gel electrophoresis and autoradiography. Isoelectric focusing 
was performed in the horizontal dimension; ( + ) and (-) indicate the acidic and 
basic ends of the gels. SDS-PAGE was performed in the vertical direction. Arrows 
mark the positions of the 52 kDa phosphoproteins detected in both fractions 
Carbamylated isoelectric focusing standards on the original gel (not shown here, 
were used to calculate the isoelectric points of these proteins. 
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FIGURE 20: Autoradiograph of a two-dimensional gel showing cAMP-binding 
proteins in apical membrane and cytosolic fractions. 
Samples from maximally stimulated (S) and unstimulated (V) P, apical membrane 
and S3 cytosolic fractions were labeled with 8-azido-[32P]-cAMP as described in 
Chapter 3. The labeled samples were then resolved using 2-D gel electrophoresis 
and autoradiography. Isoelectric focusing (IEF) was performed in the horizontal 
direction; (+) and (-) denote the acidic and basic ends of the gels. SDS-PAGE 
was performed in the vertical direction. Arrows mark the positions of the 49 kDa 
cAMP-binding protein thought to be the regulatory subunit of Type I CAPK (Rl) and 
the 52 kDa cAMP-binding protein thought to be the regulatory subunit of Type II 
CAPK (Rll). 
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points, as determined by two-dimensional gel electrophoresis, were identical with 
those of the 52 kDa phosphoproteins, it was assumed that the cAMP-binding 
proteins were in fact the same 52 kDa proteins. The sizes and isoelectric points 
of these cAMP-binding proteins also agreed with published values for Rll. 
However the distribution of the 49 and 52 kDa cAMP-binding proteins varied 
between the two subcellular fractions. The smaller cAMP-binding protein 
predominated in S3, while the 52 kDa protein was more prominant in the P, 
fraction. Thus it was inferred that Rl was the major cAMP-binding protein in 
cytosol, while Rll predominated in the apical membrane fraction. 
In stimulated cells, the 52 kDa protein also displayed different patterns of 
cAMP-binding in the two fractions. In the cytosolic fraction, it behaved much like 
the 49 kDa protein in that stimulation decreased its 8-azido-cAMP binding. In con¬ 
trast, in the membrane fraction, stimulation had no effect on the cAMP binding to 
the 52 kDa protein. 
Both forms of pp52 were immunoprecipitated by polyclonal antisera raised 
against rat heart Rll and rat brain Rll (Figure 21). However these antisera showed 
different patterns of immunoreactivity against the membrane and the cytosolic 
forms of pp52. The antisera against both heart Rll and brain Rll recognized the 
cytosolic pp52 equally well. In contrast, the membrane pp52 showed a greater 
affinity for the antibody against brain Rll. From these data, it was concluded that 
the membrane and the cytosolic forms of pp52 were two different subtypes of Rll, 
the membrane pp52 being more like the neural subtype. This conclusion might 
explain the fact that phosphorylation of membrane pp52 is independent of cAMP, 
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FIGURE 21: Autoradiograph showing immunoprecipitation of pp52 with antibodies 
against the regulatory subunit of Type II cAMP-deoendent protein kinase. 
Samples from maximally stimulated apical membrane fractions (SP') and 
unstimulated cytosolic fractions (VS3) were phosphorylated using the standard 1 
min in vitro phosphorylation reaction. The phosphorylated samples were then 
incubated with polyclonal antisera against rat heart Rll (H) and rat brain Rll (B). 
Controls were incubated with non-immune rabbit serum (N). After immunoprecipi¬ 
tation as described in Chapter 3, samples were resolved using SDS-PAGE and 
autoradiography. Arrows indicate pp52. 
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whereas phosphorylation of cytosolic pp52 is enhanced in the presence of cAMP. 
PARIETAL CELL SECRETION STUDIES 
Since okadaic acid, a phosphatase inhibitor, prevented the cAMP-dependent 
dephosphorylation of membrane pp52, the effects of okadaic acid on parietal cell 
secretion were investigated. Parietal cells were preincubated with okadaic acid for 
30 min before the addition of 10 /xM histamine. [14C]aminopyrine uptake was used 
to measure parietal cell acid sequestration, an indirect measure of acid secretion. 
Okadaic acid alone had no effect on either basal AP uptake or basal levels of 
intracellular cAMP. However the phosphatase inhibitor caused a dose-dependent 
decrease in histamine-stimulated AP accumulation (Figure 22). In the presence of 
3 /xM okadaic acid, histamine-stimulated AP uptake was decreased by 70 %. A 
similar effect was seen in cells stimulated with 10 /xM forskolin and 100 /xM 
histamine, the combination used to maximally stimulate the cells used for 
subcellular fractionation. To determine whether this effect was mediated by cAMP, 
cAMP was measured in histamine-stimulated cells. The presence of 3 *xM okadaic 
acid had no effect on the histamine-stimulated increase in cAMP (Figure 23). 
These data suggested that a protein phosphatase may play a critical role in parietal 
cell acid secretion. 
Additional studies of parietal cell acid secretion were undertaken in the 
presence of H-8, an inhibitor of cAMP dependent protein kinase with a of 1.2 
mM165. H-8 did not inhibit histamine-stimulated AP uptake at concentrations ranging 
from 0.1 /xM to 30 /iM (Figure 24). This suggested that, contrary to previous 
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FIGURE 22: The effect of the phosphatase inhibitor okadaic acid on histamine- 
stimulated [14C]aminopvrine uptake. 
Histamine-stimulated [,4C]aminopyrine ([14C]AP) uptake was measured in the 
presence of the phosphatase inhibitor okadaic acid (OA). [14C]AP uptake was 
measured as described in Chapter 3 and is expressed here as percent maximal 
uptake ± SEM (n = 4). Maximal uptake was determined in the presence of 
histamine (10 ^M) alone. [,4C]AP uptake was determined for okadaic acid 
concentrations from 10 nM to 3 mM. The concentration of histamine was 10 /xM 
for all conditions. 

80 
US Histamine Histamine 
1 /i,M 1 0 /i,M 
FIGURE 23: The effect of the phosphatase inhibitor okadaic acid on the 
histamine-stimulated increase in cAMP. 
The cellular cAMP content of isolated rabbit parietal cells was measured in the 
presence and absence of the phosphatase inhibitor okadaic acid (3 mM) as 
described in Chapter 3. Cellular cAMP content was expressed as pmol/million 
cells ± SEM (n=4). cAMP levels were measured in unstimulated cells (US), cells 
stimulated with 1 /xM histamine, and cells stimulated with 10 mM histamine. White 
bars represent the cAMP content of cells in the absence of okadaic acid; dark bars 
represent the cAMP content of cells in the presence of okadaic acid. 

81 
% MAX 
UPTAKE 
LOG [H8] 
FIGURE 24: The effect of the CAPK inhibitor H-8 on histamine-stimulated 
[14C]aminopvrine uptake. 
Histamine-stimulated [,4C]aminopyrine (f4C]AP) uptake in isolated rabbit parietal 
cells was measured in the presence and absence of the cAMP-dependent kinase 
inhibitor H-8. [,4C]AP uptake was measured as described in Chapter 3 and is 
expressed here as percent maximal uptake ± SEM (n=4). Maximal uptake was 
determined in the presence of histamine (10 ^M) alone The open circle shows 
[14C]AP uptake in the presence of histamine (10 mM) alone. The closed circles 
show the effect of H-8 (10 nM to 30 mM) on histamine (10 MM)-stimulated [14C]AP 
uptake. 
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assumptions, activation of CAPK might not be an integral step in histamine- 
stimulated acid secretion. 
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CHAPTER 5 
DISCUSSION 
HISTAMINE-STIMULATED ACID SECRETION: THE CLASSICAL MODEL 
Previous work in the parietal cell has assumed that the histamine-stimulated 
increase in acid secretion was mediated by the cAMP-dependent protein kinase 
(Figure 25 ) 69 70,71,72'73'74'75. Histamine elicited a sustained increase in the intracellular 
cAMP concentration of the parietal cell36,37. Histamine also activated parietal cell 
CAPK67 68 69 70,71. These data led to the assumption that CAPK mediated histamine- 
stimulated acid secretion, presumably by phosphorylating key protein inter¬ 
mediates. 
HISTAMINE-STIMULATED ACID SECRETION: A NEW MODEL 
The data presented here suggest that while secretion still appears to be 
mediated by cAMP, the cyclic nucleotide does not act solely via CAPK, since the 
addition of the CAPK inhibitor H-8 to whole parietal cells did not affect acid 
secretion. At least one other investigator has reported a similar finding, in which 
cAMP-dependent exocytosis did not appear to be mediated by CAPK". 
Our data demonstrate that histamine stimulation of rabbit parietal cells 
affects the phosphorylation state of a 52 kDa protein that is found in the apical 
membrane-rich fraction. Both kinase and phosphatase activities in this fraction 
have been characterized. Furthermore, the 52 kDa substrate has been identified 
as the neural subtype of the regulatory subunit of Type II CAPK. Okadaic acid, a 
phosphatase inhibitor, inhibits both the dephosphorylation of this protein and the 

FIGURE 25: Histamine-stimulated acid secretion: the classical model. 
1) In the resting cell, cAMP-dependent kinase (CAPK) is found in the inactive form. 
2) Histamine stimulation increases the intracellular concentration of cAMP. 3) 
CAMP binds to the regulatory subunit of CAPK, releasing active catalytic subunit. 
4) The free catalytic subunit phosphorylates protein X. 5) The phosphorylated 
protein acts as an intermediary in histamine-stimulated acid secretion. H - 
histamine; H2 - type 2 histamine receptor; C - catalytic subunit of CAPK; X - a pro¬ 
tein; X-P - the phosphorylated form of the protein. 
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secretion of acid by the parietal cell. This suggests that a phosphatase plays a 
key role in histamine-stimulated acid secretion. 
These data have led us to propose a new mode! for histamine-stimulated 
parietal cell acid secretion (Figure 26). 1) In the resting state, Rll is phosphorylated 
by a kinase that has not yet been identified. 2) Histamine stimulation increases the 
concentration of intracellular cAMP. 3) Cylic AMP binds to apical membrane Rll, 
changing its conformation. 4) This change in conformation makes a phosphate 
group accessible to an apical membrane phosphatase that dephosphorylates Rll. 
5) The dephosphorylated Rll promotes acid secretion by an unknown mechanism. 
It is possible that cAMP directly or indirectly acts on the phosphatase rather 
than the substrate. However since Rll is known to be a cAMP-binding protein it 
is more likely that the effect of cAMP is substrate-mediated. The physiological 
role of this phosphorylation change is not yet known. Since previous data have 
shown Rll to be associated with cytoskeletal elements'43 146, Rll may influence the 
cytoskeletal changes associated with parietal cell acid secretion21 22,23. The 
dephosphorylation of apical membrane Rll may activate CAPK and directly or in¬ 
directly cause the phosphorylation of cytoskeletal elements. However other 
investigators have found that Type II CAPK is not activated in histamine-stimulated 
parietal cells71. It is therefore possible that the apical membrane Rll interacts with 
the cytoskeleton through a function other than its regulation of CAPK. 
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FIGURE 26: Histamine-stimulated acid secretion: a new mndPl 
1) In the resting state, a membrane-bound kinase phosphorylates the apical 
membrane Rll. 2) Histamine stimulation increases the intracellular concentration 
of cAMP. 3) cAMP binds to Rll, changing its conformation. 4) This change in 
conformation makes the phosphate group accessible to an apical membrane 
phosphatase. 5) The dephosphorylated Rll acts as an intermediary in histamine- 
stimulated acid secretion. H - histamine; H2 - type 2 histamine receptor’ P - 
phosphate. ’ 
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Identification of the phosphatase 
Several phosphatases have been reported to cause the cAMP-dependent 
dephosphorylation of rh166 127 124133 167 These generally require cAMP concentrations 
between 4 and 25 mM, close to the concentration used in our experiments. 
However our data characterizing the apical membrane phosphatase activity differed 
from previously published reports, suggesting that there may be more than one 
cAMP-dependent phosphatase that acts on Rll. Most of the cAMP-dependent 
phosphatases described in the literature are inhibited by phosphatase inhibitors 
such as NaF and ZnCI2. These agents did not affect the activity of the apical 
membrane phosphatase in our preparation. This difference may also reflect 
differences in the substrate. In at least one instance, the phosphatase was 
probably acting on the non-neural form of Rll, since dephosphorylation altered its 
electrophoretic mobility133. In contrast, our data suggest that the phosphatase 
substrate in the apical membrane fraction is probably the neural form of Rll. 
While most of the phosphatases that have been reported to act on Rll show 
cAMP dependence, Blumenthal et aL have described an interesting calmodulin- 
dependent phosphatase that catalyzes the removal of a phosphate group from the 
autophosphorylated serine-95 of Rll168. This phosphatase, also known as 
calcineurin, has been reported to bind tightly to Type II CAPK from brain via the 
regulatory subunit169. As mentioned earlier, Rll is known to interact with proteins 
other than the regulatory subunit of CAPK143 144 145. It is unlikely that this phospha¬ 
tase is the same as that identified in the apical membrane fraction of stimulated 
parietal cells. The calmodulin-dependent phosphatase activity was completely 
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inhibited by 2 mM EDTA, whereas the dephosphorylation of Rll in the apical 
membrane was completely unaffected by the addition of 10 mM EDTA. 
Although there are no other reports of histamine-stimulated phosphatases 
in the parietal ceii, Im et aL have identified a phosphatase in membranes prepared 
from the stomachs of carbachol-injected rats170. Like the P, fraction used in our 
experiments this membrane preparation was enriched in the H+/K+-ATPase. 
However unlike the histamine-stimulated phosphatase described here, the car- 
bachol-stimulated phosphatase was inhibited by NaF, ZnCI2, and pyrophosphate. 
The carbachol- and histamine-stimulated phosphatase activities are therefore 
unlikely to be the result of the same enzyme. 
Although a number of phosphatases that act on Rll have been described, 
most of these descriptions are not compatible with the data from the rabbit parietal 
cell. This may reflect the fact that these phosphatases act on a different 
phosphorylation site and/or subtype of Rll. However Kiss et aL have identified a 
CAPK catalytic subunit-independent kinase and a cAMP-dependent phosphatase 
that act on Rll in rat liver membranes. These appear to be similar to the activities 
seen in parietal cell membranes134. The addition of NaF did not inhibit phospha¬ 
tase activity in either preparation. Furthermore, in both cases the site of phos¬ 
phorylation and dephosphorylation appeared to be a site other than the autophos¬ 
phorylation site of Rll. 
Several pieces of evidence support the conclusion that the phosphorylation 
site of interest on apical membrane Rll is not the autophosphorylation site. First, 
the autophosphorylation of serine-95 has a Ky? for ATP of approximately 0.4 /iM123. 
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The phosphorylation of the apical membrane Rll has a K/2 that is approximately 
tenfold higher. Second, the addition of CAPK catalytic subunit does not increase 
the phosphorylation of the site on the apical membrane Rll, as would be expected 
if it were the autophosphorylation site. Other sites on Rll that are known to be 
phosphorylated are the serines-44 and-47 phosphorylated by glycogen synthase 
kinase 3 (GSK 3)128, and the serines-74 and -76 phosphorylated by casein kinase 
II (CK II)129. However immunoprecipitation with antibodies against heart and brain 
Rll has shown that the apical membrane Rll more closely resembles the neural 
form of Rll, which does not possess the consensus sequence for phosphorylation 
by GSK 3142. While it is possible that the apical membrane Rll is phosphorylated 
at a site that has not been previously described, the data also support the 
possibility that the apical membrane Rll is phosphorylated and dephosphorylated 
at the CK II site. 
The phosphatase activity seen in apical membranes from stimulated rabbit 
parietal cells therefore seems to be a type I phosphatase that removes a 
phosphate group from the CK II site of Rll. Like the activity described by Kiss et 
aL170, this phosphatase is dependent on cAMP but not inhibited by NaF. 
Identification of the kinase 
In the resting state, the apical membrane Rll presumably returns to the 
phosphorylated state. It is not known which kinase mediates this reaction. The 
catalytic subunit of CAPK is unlikely to be responsible, since it is thought to 
phosphorylate only serine-95. It is possible that CK II phosphorylates the apical 
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membrane Rll. CK II is a ubiquitous protein kinase found in many different 
organisms and species171. Despite its widespread occurrence and ability to 
phosphorylate a number of different substrates in vitro, it has as yet no known 
physiological substrates. The kinase that phosphorylates the apical membrane Rll 
exhibits several features that make CK II a likely candidate. Like CK II, the apicai 
membrane Rll kinase is able to use both ATP and GTP as phosphate donors but 
has a greater affinity for ATP172. Furthermore, both kinases are also active over a 
wide pH range. While these data do not conclusively identify the apical membrane 
Rll kinase, it is possible that Rll will be the first substrate reported to be phospho- 
rylated by CK II under physiological conditions. 
Other forms of Rll in the parietal cell 
The form of Rll identified in the cytoplasm of rabbit parietal cells does not 
appear to be a substrate for the kinase and phosphatase that act on the apical 
membrane Rll. Based on their immunoreactivity, we have hypothesized that the 
membrane Rll and the cytosolic Rll are two different subtypes of Rll. The former 
appears to resemble the neural form, while the latter is probably closer to the non- 
neural variety. This hypothesis might explain why histamine stimulation of rabbit 
parietal cells affects the membrane and cytosolic forms of Rll differently. An 
analogous situation has been observed in Friend erythroleukemic cells137. When 
these cells were stimulated to differentiate, one form of Rll increased while the 
other was unaffected. This difference in response may reflect modifications to the 
two forms of Rll that make them react differently to stimuli. However it may also 
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reflect the subcellular distribution of Rll subtypes. The different forms of Rll may 
be found in separate intracellular compartments, and individual stimuli may exert 
their effects only at selected locations within the cell. 
CONCLUSION 
The data presented here support a new model for histamine-stimulated 
parietal cell acid secretion in which the phosphorylation state of a neural-type Rll 
in the apical membrane plays a critical role. Whole cell secretion data indicate that 
a phosphatase activity is essential to histamine-stimulated acid secretion. 
Histamine stimulation of isolated rabbit parietal cells appears to activate a mem¬ 
brane-associated type 1 phosphatase that dephosphorylates the apical membrane 
Rll. The apical membrane also contains a kinase that phosphorylates the 
membrane-associated Rll. The data indicate that this kinase may be casein kinase 
II. While the phosphorylation site of the apical membrane Rll has not been conclu¬ 
sively identified, the data suggest that this may be the site phosphorylated by 
casein kinase II in vitro. The parietal cell also contains a cytosolic form of Rll that 
is not a substrate for the histamine-stimulated apical membrane phosphatase. The 
cytosolic Rll appears to resemble the non-neural subtype of Rll. 
FUTURE DIRECTIONS 
While this work provides some insight into the molecular mechanism of acid 
secretion, a number of key questions remain to be answered. First, it must be 
conclusively demonstrated in whole cell experiments that histamine stimulation 
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leads to the dephosphorylation of Rll. Second, the Rll subtypes in the parietal cell 
must be purified and characterized. Third, the phosphorylation site on apical 
membrane Rli needs to be specifically identified and its biochemical function under¬ 
stood. Fourth, the apical membrane kinase and phosphatase must be purified and 
identified. Fifth, it must be determined whether apical membrane Rll exerts its 
effects through CAPK or whether it is associated with other effector proteins. Last¬ 
ly, it must be seen whether other secretagogues that promote acid secretion, such 
as carbachol and gastrin, are also able to affect the phosphorylation state of Rll. 
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